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1. INTRODUCTION 
 
 
1.1 The age of Proteomics 
 
Once complete genome sequencing has been achieved for a wide variety 
of procariotic and eucariotyc organisms, one of the most intellectually 
challenging, scientifically productive, and socially applicable endeavours of 
modern biological science is the current effort to understand the function of 
living cells at the molecular level. Therefore interest has inevitably turned to 
proteins. 
The term 
“proteome”  (1) 
indicates 
PROTEins 
expressed by a 
genOME and is 
the systematic 
analysis of 
protein profiles, 
it refers to all 
protein produced by a species. 
Whereas the genome is a constant feature of an organism, the proteome 
varies with nature of tissue, state of development, health or disease, effect 
of drug treatment and in response of environmental changes (such as lack 
of nourishments, oxidative stress, UV exposition and ageing) (2,3). 
This capacity might be pointed to the ability of a proteome to regulate 
dynamically protein expression (4) and post translational modification; it’s 
now known that products of a single gene represent a protein population 
that can contain large amounts of micro heterogeneity (5). More than 100 
modification types are recorded and additional ones are yet to be 
discovered  (6). 
Proteomics can be divided into expression proteomics (7,8,9), the study of 
global protein expression, and functional proteomics (10, 11, 12), the 
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study of proteins function and their interaction through the isolation of 
protein complexes. However, there is a distinction to be made between the 
molecular function of an isolated protein and the function of that protein in 
the complex cellular environment  as studied by proteomics technologies. 
Proteomics attempts to catalog and characterize these proteins, compare 
variations in their expression level in health and disease, study their 
interactions, and identify their functional roles. Proteomics is not the study 
of individual 
proteins as 
has been 
done 
traditionally, 
but rather a 
study of 
protein 
complexes 
time and 
environment
al condition 
depending. 
The described scenario requires advanced methodologies based on the 
combination of the classical biochemical approach coupled with all the 
modern available technologies. On the one hand, in fact, a huge and 
sensitive analytical capacity is required, but on the other hand a deep 
knowledge of protein chemistry is fundamental. The only analytical skills 
may lead to enormous mistakes. 
A proteomic investigation mix together separative methods (such as two 
dimensional electrophoresis, liquid chromatography), mass spectrometry 
and bioinformatics (Fig 1); the enormous quantity of data produced must 
be analyzed by a biochemist in order to find all the relations giving a sense 
to his research. 
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Fig1     
                                    
 
 
 
 
 
 
 
 
 
 
 
1.2        Proteomics methods 
 
1.2.1 Two dimensional electrophoresis 
 
Two-dimensional gel electrophoresis (2-DE) is a powerful and widely used 
method for the analysis of complex protein mixtures extracted from cells 
(13), tissues (14), or other biological samples. This technique separate 
proteins in two steps, according to two independent properties: the first-
dimension is an isoelectric focusing (IEF), which separates proteins 
according to their isoelectric points (pI); the second-dimension is an SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), which separates proteins 
according to their molecular 
weights (MW). In this way, 
complex mixtures composed by 
different proteins can be 
resolved. 
During the first dimension the 
procedure involves placing the 
sample in gel with a pH gradient, 
and applying a potential 
difference across it. In the electrical field, the protein migrates along the pH 
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gradient, until it carries no overall charge. This location of the protein in the 
gel constitutes the apparent pI of the protein.  
There are two alternatives methods to create the pH gradient - carrier 
ampholites and immobilized pH gradient (IPG) gels (15). 
 Development of IPG coupled with pre-cast gradient polyacrylamide gels 
and introduction of new sensitive fluorescent stains have considerably 
simplified and greatly improved the 
capacity, sensitivity and reproducibility 
of 2D gels. The IEF is the most critical 
step of the 2-DE process. The proteins 
must be solubilized without charged 
detergents, usually in high 
concentrated urea solution, reducing 
agents and chaotrophs. To obtain high 
quality data it is essential to achieve 
low ionic strength conditions before the IEF it self. Since different types of 
samples differ in their ion content, it is necessary to adjust the IEF buffer 
and the electrical profile to each type of sample.  
 
The separation in the 
second dimension by 
molecular size is performed 
in slab SDS-PAGE gels. Up 
to twelve parallel gels can 
be simultaneously 
separated in a fixed 
temperature to minimize 
the separation variations 
between individual gels.  
These recent technological 
advances do not however eliminate a number of difficulties associated with 
the separation of proteins by 2DE. 
The complexity of a proteome can far exceed the capacity of analytical 
systems. The whole proteome of any organism, in fact is too complicated 
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to be analyzed in a simple one-step process and direct attempts for the 
entire proteome analysis normally lead to limited amount of information 
(16, 17).  
Historically, 2DE has been the tool of choice to resolve complex protein 
mixtures and to detect differences in protein expression patterns between 
normal and diseased tissue. 
High-resolution gel electrophoresis, of which 2DE is currently the most 
powerful protein separation method, was already used as an analytical tool 
in the late 70s (18, 19). Despite these outstanding properties and 
widespread application, almost 20 years went by before systematic use of 
2D PAGE gels became an integral part of the proteomics. The protein 
spots were elettroblotted on the membrane and analyzed by Edman 
degradation to release N-terminal sequence (20); this approach was 
generally slow because every protein spot or peptide peak had to be 
sequenced individually. In addition this identification method has low 
sensibility and there was not complete database of genome. Furthermore, 
proteins are often blocked at their N-terminal in the course of the 
biosynthesis (acetylation, formylation or pyroglutamic formation).  
2-DE remained the highest resolution protein separation method available, 
but the ability to identify the observed proteins was always an extremely 
difficult problem. In the past decade, three crucial developments have 
changed this situation. The first: whole genome sequencing for an 
increasing number of organisms has defined at the gene level all proteins 
that exist in that organism. The second: the development of mass 
spectrometers able to ionize and mass-analyze biological molecules. The 
third: the development of computer algorithms able to match MS and 
MS/MS spectra. Recently, the significant accomplishments of genomics, 
proteomics and bioinformatics are making the systematic analysis of all 
expressed cellular components a reality. Together with the completion of 
several genome projects and the development of bioinformatics tools for 
protein research, the groundwork was laid for rapid, sensitive, and accurate 
studies of protein in many biological organisms. Today MS is 
overwhelmingly used as the technology base for protein identification from 
2D gels (21, 22, 23)  
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The comparative 2D gel approach is typically employed to study 
differences in proteins that are up- or down-regulated in a disease state. In 
such studies, a reliable analysis of quantitative changes of protein spots is 
important (24, 25). Furthermore, recently new programs for comparison of 
2D-maps like algorithms based on characteristics of spot image on gel are 
rising. Well-known drawbacks of the technique are limitations in the pI and 
molecular weight of proteins. In fact, specific classes of proteins have long 
been known to be excluded or under-represented in 2D gel patterns. These 
include very acidic or basic proteins, excessively large or small proteins 
and membrane proteins. Furthermore, difficult automation and 
reproducibility problems and low abundant proteins are either not detected 
at all, due to the limited sensitivity achievable with commonly used dyes, or 
they are masked by higher abundant comigrating proteins. Incremental 
improvements in 2DE technology, including more sensitive staining 
methods (26), large-format higher resolving gels (27, 28) and sample 
fractionation (29) prior to 2DE have alleviated, but not eliminated, these 
and other shortcomings of the 2DE/MS approach. 
 
 
 
1.2.2 Image analysis 
 
The crucial algorithms in 2-D gel analysis software have been significantly 
improved over the years (30, 31) in order to account for such difficulties. In 
addition, program interfaces have gained a lot of ground in user 
friendliness. In spite of these advances, no image analysis software can 
solve all experimental problems. The desire to draw valuable information 
from low quality gels remains an illusive goal. Before starting a 2-D gel 
image analysis, it is therefore essential to optimize all steps in the gel 
production process in order to assure the best possible quality and 
reproducibility. Careful experimentation remains the only way to guarantee 
significant end results; image acquisition parameters also play a very 
important role.  
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During an image analysis a gel can be considered as a “2-DE image” that 
has been digitized and stored on a hard disk. It contains the raw input data 
from which proteins can be detected and quantified. The proteins represent 
the gray (or dark blue) values for all the pixels in the image. Every pixel is 
characterized by its X and Y coordinates, which represent the horizontal 
and vertical positions of the pixel on the image. The pixel's raw value, or 
gray value, is the signal intensity of the pixel (Z axis in a three-dimensional 
view) Fig 2.  
                 
                   Fig 2. 3-D view for several gel regions. 
                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The software recognizes gels from several image formats. Gels can be 
duplicated, deleted, cropped, filtered, flipped or scaled. Gels can also be 
aligned, meaning that they are distorted in order to superimpose their 
image with another gel. Various items can be defined on a gel for detailed 
examination. 
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Spot and gel relationships 
 
Matches 
A match represents the relationship between corresponding spots in 
different gels. It connects the same protein in the different gels. It is 
composed of a spot n-tuple (S1, S2, ..., Sn) where S1 is a spot in the first 
gel, and Sn a spot in the last gel. Matches can be manually defined by the 
user or automatically determined by software's powerful gel matching 
algorithm. The match is the basic element for searching and investigating 
protein expression changes across gels through the use of reports, 
histograms, and statistical methods. 
To be able to initiate the matching process, gels must be part of a Match 
set. A match set includes gels or populations of gels (in sub match sets) 
that should be compared and therefore matched together. Every match set 
is represented by a Master image. This master image is created by based 
on the Reference for the match set, chosen by the user. 
A class is a set of gels or gel populations that you can compare with other 
such entities. For example, a class of gels obtained from the infected tissue 
samples of different patients can be compared to a class of gels 
representing healthy tissue from other patients. 
A class allows to search and investigate protein expression changes 
across gels through the use of intra-class reports, histograms, and scatter 
plots. It is also possible to compare different classes through inter-class 
analyses. To compare gels in a class or within different classes, the gels 
must be matched together. This means that they must belong to the same 
match set. 
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Figure 3. Definition of matches, match sets and classes. Spots S1, S2, S3, 
and S4 together form a match. Note that the spot in Master AB has the 
same number as the corresponding spot in A1. This is because A1 is the 
reference image for Match set AB, on which the Master AB is based. The 
Match set AB contains all the gels to be matched (A1, A2, B1 and B2), and 
is represented by a master image (Master AB). A class regroups gels from 
a particular biological state for comparison with another such state. The 
spots in the selected match (green) are under-expressed in Class B with 
respect to Class A. 
 
This statistical relation between all the compared spots intensity may be 
obtained, therefore the choice of the most interesting spot to be identified 
becomes easier. 
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1.2.3 Protein Identification by mass spectrometry      
 
In proteomics Mass 
Spectrometry, 
together with two-
dimensional gel 
electrophoresis, 
emerged as the 
leading technology, 
due to its high 
sensitivities and the 
ability of generating 
data rapidly. Thus it 
has a great 
potential for high-
throughput analysis 
required by this kind of approach. The ability to identify proteins rapidly 
using mass spectrometry data has catalyzed the development of methods 
for large scale protein analysis as well as the development of new 
approaches to analyze protein mixtures and complexes (32, 33, 34,). 
The growing utility of mass spectrometry in biological research derives 
from the development of two extraordinary methods for ionizing 
biomolecules, matrix-assisted laser desorption/ionization (MALDI) and 
electrospray ionization (ESI). These techniques enable the determination 
of the molecular mass of peptides and proteins with high accuracy and 
speed. 
Atomic resolution structure determinations of proteins are formidable 
multidisciplinary undertakings encompassing tasks such as protein cloning, 
expression and purification procedures, crystallization trials, phase 
determination and model building. The mass spectrometry can greatly 
facilitate these obligate tasks (35, 36). It can be used for assaying the 
correctness and purity of target protein constructs, due to its unsurpassed 
accuracy and speed for measuring mass, mass spectrometry allows to 
quickly test whether a given protein has been faithfully expressed. The 
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measurement allows for detection of PCR errors, mistranslation errors, 
unwanted modifications, and major protein impurities. Additional 
information concerning the nature of the error/modification can be obtained 
by MS peptide mapping. 
A mass spectrometer consists of an ion source, a mass analyser that 
measures the mass-to-charge ratio (m/z) of the ionized analytes, and a 
detector that registers the number of ions at each m/z value.  
MALDI-MS is normally used to analyze peptide mixtures, whereas 
integrated liquid-chromatography ESI-MS systems (LC-MS) are preferred 
for the analysis of complex samples. 
There are four basic types of mass analyser currently used in proteomics 
research. These are the ion trap, time-of-flight (TOF), quadrupole and 
Fourier transform ion cyclotron (FT-MS) analysers. They are very different 
in design and performance, each with its own strength and weakness. 
These analysers can be stand alone or, in some cases, put together in 
tandem to take advantage of the strengths of each. 
Two mass spectrometric methods for rapid identification of proteins are 
now in widespread use: one of these methods (MALDI) uses the 
characteristic distribution of peptide masses obtained by chemical or 
enzymatic hydrolysis of proteins (37, 38). A number of computer programs 
are available for using the observed peptide masses to search gene 
sequence databases for proteins that fit the mass fingerprint (39, 40, 41).  
For this method the combination of the high resolution power of 2DE and 
the rapidity of MALDI analysis is the best combination. MALDI in fact may 
be considered the fastest technique for peptide analysis.  
The other method for protein identification uses sequence tags (42, 43); 
i.e., partial amino acid sequence information. Searching of gene sequence 
databases is again used to identify the protein at the gene level.  
The outcome of the experiment is the identity of the peptides and therefore 
the proteins making up the purified protein population. Often MS/MS 
instruments are classified in one or two categories: tandem in space or 
tandem in time. Tandem in space instruments require a distinct analyser 
for each stage (isolation and fragmentation) of MS/MS. Today, almost all 
tandem in space MS-MS instruments are either triple quadrupole (QqQ) or 
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hybrid instruments quadrupole/time-of-flight (Q/TOF). Trapping instruments 
are typically tandem in time. The various stages of MS-MS are performed 
in the same analyzer but separated in time.  
 
Peptide Sequence analysis  
 
The technique of tandem mass spectrometry (MS-MS) is an important 
factor in the contributions of the application of mass spectrometry to 
biological compounds. As the name implies, MS/MS involves two stages of 
MS. In the first stage of MS-MS, ions of a desired m/z are isolated from the 
rest of the ions coming from the ion source. These isolated ions (termed 
parent ions) are then induced to undergo a reaction that increases the 
internal energy of the ions, leading to dissociation. The ions resulting from 
the various reactions are termed product ions, and these are analyzed with 
the second stage of MS-MS. The representation of this can be summarized 
in reaction in which mp+ is the parent ion, md+ is the product or fragment ion 
and mn the neutral fragment or another product ion if the parent ion is 
multiply charged: 
 
mp+ → md+ + mn 
 
With some instrument, it’s possible to repeat this process, leading to what 
is termed an MSn experiment, where n is equal to the number of stages of 
MS performed. A crucial aspect of the MS-MS experiment is the reaction 
that occurs between the two MS stages. By far the most frequent reaction 
is unimolecolar dissociation, which is generally enhanced by some form of 
ion activation. The ion activation is necessary to increase the internal 
energy of the parent ion so that it will dissociate before analysis by MS2. In 
practice, the activation cannot be separated from the dissociation, so the 
ion activation techniques are typically referred to as dissociation methods. 
The dissociation method almost universally used is collision-induced 
dissociation (CID) (44, 45). In CID, the parent ion collides with a neutral 
target (collision) gas and some of the kinetic energy of the parent ion can 
be converted to internal energy. High energy CID spectra (keV) tend to be 
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dominated by fragment ions formed by charge-remote mechanism, while 
low energy CID spectra (< 100 eV) often show intense fragment ions 
formed by abundant neutral losses. The CID spectra of peptides recorded 
at low collision energy tend to show abundant fragment ions formed by 
cleavage of the peptide bonds, while high-energy CID spectra often contain 
fragment ions formed by other backbone and also side-chain cleavages . 
Peptide sequence identification by mass spectrometry involves 
fragmentation of a peptide to produce smaller m/z fragments; ideally, 
measured m/z values of these pieces can be assembled to produce the 
original sequence. Cleavage is commonly accepted to occur predominantly 
through charge-directed pathways.  
A nomenclature exists to describe the fragment ion types that are produced 
by cleavage of different bonds along the peptide backbone and/or side 
chain. Cleavage of the backbone typically occurs at the peptide bond to 
produce b ions, if the amino terminal fragment retains the charge, or y ions, 
if the carboxy-terminal fragment retains the charge (fig. 4). In the case of 
multiply charged ions, a charge separation can occur to produce 
complementary ion pairs. Both partners of the complementary pair are not 
always detected in equal abundance, because they are not equally stable 
against further fragmentation or because instrument discrimination may 
enhance or diminish one partner of the pair. Although b and y ions are 
considered to be the most useful sequence ion types, because they 
correspond to cleavage of the amide bond, other ion types are observed 
and used in spectral interpretation. These include an ions which 
correspond formally to loss of CO from b ion; a m/z difference of 28 
between two peaks suggests an a-b ion pair and is useful in identifying the 
ion series to which the peaks belong. The y series is sometimes 
accompanied by peaks formally corresponding to loss of NH3 from the y 
ions, allowing designation of the higher m/z ion each delta 17 pair as 
belonging to the y ion series. Ions that correspond to immonium ions, or 
fragments of immonium ions, of individual amino acid residues in a peptide 
are often detected, even for residues from the internal portion of the 
sequence (86).  
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Fig.4 Schematic representation of nomenclature for fragmentation of 
peptide ions. 
 
 
 
MALDI mass fingerprinting 
 
The term matrix-assisted laser desorption ionization (MALDI) was coined in 
1985 by Franz Hillenkamp, Michael Karas and their colleagues (46). These 
researchers found that the amino acid alanine could be ionized more easily 
if it was mixed with the amino acid tryptophan and irradiated with a pulsed 
266 nm laser. The tryptophan was absorbing the laser energy and helping 
to ionize the non-absorbing alanine. Peptides up to the 2843 Da  (melittin) 
could be ionized when mixed with this kind of “matrix” (46,47,48). The 
breakthrough for large molecule laser desorption ionization came in 1987 
when Koichi Tanaka of Shimadzu Corp. and his co-workers used what they 
called the “ultra fine metal plus liquid matrix method” that combined 30 nm 
cobalt particles in glycerol with a 337 nm nitrogen laser for ionization (46). 
Using this laser and matrix combination, Tanaka was able to ionize 
biomolecules as large as the 34,472 Da protein carboxypeptidase-A. 
Tanaka received one-quarter of the 2002 Nobel Prize in Chemistry for 
demonstrating that, with the proper combination of laser wavelength and 
matrix, a protein can be ionized (49). Karas and Hillenkamp were 
subsequently able to ionize the 67 kDa protein albumin using a nicotinic 
acid matrix and a 266 nm laser (46) 
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. Further improvements were realized through the use of a 355 nm laser 
and the cinnamic acid derivatives ferulic acid, caffeic acid and sinapinic 
acid as the matrix (50). The availability of small and relatively inexpensive 
nitrogen lasers operating at 337 nm wavelength and the first commercial 
instruments introduced in the early 1990s brought MALDI to an increasing 
number of researchers (51,52). Today, mostly organic matrices are used 
for MALDI mass spectrometry. 
Matrix-assisted laser desorption/ionization (MALDI) is a soft ionization 
technique used in mass spectrometry, allowing the analysis of 
biomolecules (biopolymers such as proteins, peptides and sugars) and 
large organic molecules (such as polymers, dendrimers and other 
macromolecules), which tend to be fragile and fragment when ionized by 
more conventional ionization methods. It is most similar in character to 
electrospray ionization both in relative softness and the ions produced 
(although it causes much fewer multiply charged ions). 
The ionization is triggered by a laser beam (normally a nitrogen laser). A 
matrix is used to protect the biomolecule from being destroyed by direct 
laser beam and to facilitate vaporization and ionization 
The matrix consists of crystallized molecules, of which the three most 
commonly used are 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid), 
-cyano-4-hydroxycinnamic acid (alpha-cyano or alpha-matrix) and 2,5-
dihydroxybenzoic acid (DHB). A solution of one of these molecules is 
made, often in a mixture of highly purified water and an organic solvent 
(normally acetonitrile (ACN) or ethanol). Trifluoroacetic acid (TFA) may 
also be added. A good example of a matrix-solution would be 20 mg/mL 
sinapinic acid in ACN:water:TFA (50:50:0.1). 
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Fig 5. Matrix-assisted laser desorption ionization depicted with matrix in 
blue and analyte in green 
 
The identity of suitable matrix compounds is determined to some extent by 
trial and error, but they are based on some specific molecular design 
considerations: 
• They are of a fairly low molecular weight (to allow facile vaporization), but 
are large enough (with a high enough vapour pressure) not to evaporate 
during sample preparation or while standing in the spectrometer.  
• They are acidic, therefore act as a proton source to encourage ionization 
of the analyte; a matrix molecule have a strong optical absorption in the 
UV, so that they rapidly and efficiently absorb the laser irradiation.  
The matrix solution is mixed with the analyte (e.g. protein-sample). The 
organic solvent allows hydrophobic molecules to dissolve into the solution, 
while the water allows for water-soluble (hydrophilic) molecules to do the 
same. This solution is spotted onto a MALDI plate (usually a metal plate 
designed for this purpose). The solvents vaporize, leaving only the 
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recrystallized matrix, but now with analyte molecules spread throughout the 
crystals. The matrix and the analyte are said to be co-crystallized in a 
MALDI spot. 
 
The laser is fired at the crystals in the MALDI spot. The spot absorbs the 
laser energy and it is thought that primarily the matrix is ionized by this 
event. The matrix is then thought to transfer part of its charge to the 
analyte molecules (e.g. protein), thus ionizing them while still protecting 
them from the disruptive energy of the laser. Ions observed after this 
process are quasimolecular ions that are ionized by the addition of a proton 
to [M+H]+, or other cation such as sodium ion [M+Na]+, or the removal of a 
proton [M-H]- for example. MALDI generally produces singly-charged ions, 
but multiply charged ions ([M+nH]n+) can also be observed, usually in 
function of the matrix used and/or of the laser intensity, voltage. Note that 
these are all even-electron species. Ion signals of radical cations can be 
observed eg. in case of matrix molecules and other stable molecules. 
 
 
 
 
 
 
 
 
 
 
 
 
Lasers Used for MALDI 
Laser Wavelength (nm) Reference 
Nitrogen laser 337 (Tanaka 1988) 
Nd:YAG 355, 266 (Karas 1985) 
Er:YAG 2940 (Overberg 1990) 
CO2 10,600 (Overberg 1991) 
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Time Of Flight analyzer  
The most widely used  analyzer is the TOF (time-of-flight mass 
spectrometer), mainly due to its large mass range. The TOF measurement 
procedure is also ideally suited to the MALDI ionization process since the 
pulsed laser takes individual 'shots' rather than working in continuous 
operation. MALDI-TOF instruments are typically equipped with an "ion 
mirror", deflecting ions with an electric field, thereby doubling the ion flight 
path and increasing the resolution. Commercial reflector TOF instruments 
reach today a resolving power m/m of well above 20'000 FWHM (full-
width half-maximum, m defined as the peak width at 50% of peak height). 
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The flight tube is usually a vacuum enclosure, free of electrical fields, 
between the ion source and the detector. It is sometimes referred to as a 
“field free drift region”. 
The ions which are under study exit the ion source and enter the flight tube 
with the proper velocity and direction to arrive at the detector. The flight 
tube does not usually interact with the ion packets along their flight path. If 
the ions are created at a positive voltage and accelerated to ground 
potential, the flight tube can be a simple pipe. 
 
 
 
 
 
 
 
 
 
 
Ions are pulsed into the flight tube in short, well defined packets. All the 
ions are given the same energy in the source. Since the light ones were 
pushed just as hard as the heavy ones, they will travel faster. 
Since they are travelling at different velocities, the ion packets become 
strung out as they travel down the flight tube. The light ions (Fig 6, a) in 
front, and the heavier ones (Fig 6, b) in back. Given sufficient flight time, 
the ions become separated into individual packets (Fig 6, c) by mass 
number. The detector amplifies them sequentially, and each packet 
becomes a mass peak. 
The equation governing TOF separation is: 
 
 
 
 
Fig. 6 
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m/z is mass-to-charge ratio of the ion 
E is the extraction pulse potential 
s is the length of flight tube over which E is applied 
d is the length of field free drift zone 
t is the measured time-of-flight of the ion 
 
The initial MS spectrum determining the molecular masses of all of the 
components in the digest mixture can often provide sufficient information to 
search a database using just several of the molecular weights from this 
peptide map, the so called Peptide Mass Fingerprinting (PMF) of a protein. 
Peptide Mass Fingerprinting (PMF) is a technique used to identify proteins 
by matching their constituent fragment masses (peptide masses) to the 
theoretical peptide masses generated from a protein or DNA database.  
The first step in PMF is that an intact, unknown protein is cleaved with a 
proteolytic enzyme to generate peptides. With PMF, heterogeneity is most 
commonly imparted to the unknown protein with a trypsin digestion.  A 
PMF database search is usually employed following MALDI TOF mass 
analysis.  The premise of peptide mass finger printing is that every unique 
protein will have a unique set of peptides and hence unique peptide 
masses. Identification is accomplished by matching the observed peptide 
masses to the theoretical masses derived from a sequence database.  
PMF identification relies on observing a large number of peptides, 5+, from 
the same protein at high mass accuracy.  This technique does well with 2D 
gel spots where the protein purity is high. PMF protein identification can 
run into difficulties with complex mixtures of proteins. Low level ID also 
becomes difficult due to commonplace contamination by keratin. 
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1.2.4 Software and bioinformatics 
 
The terms bioinformatics and computational biology are often used 
interchangeably.  
 
 
H
o
w
e
v
e
r
 
b
i
o
i
n
f
o
rmatics more properly refers to the creation and advancement of 
algorithms, computational and statistical techniques, and theory to solve 
formal and practical problems inspired from the management and analysis 
of biological data. Computational biology, on the other hand, refers to 
hypothesis-driven investigation of a specific biological problem using 
computers, carried out with experimental or simulated data, with the 
primary goal of discovery and the advancement of biological knowledge. 
More simply, bioinformatics is concerned with the information while 
computational biology is concerned with the hypotheses. A similar 
distinction is made by National Institutes of Health (U.S.A.) in their working 
definitions of Bioinformatics and Computational Biology, where it is further 
emphasized that there is a tight coupling of developments and knowledge 
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between the more hypothesis-driven research in computational biology and 
technique-driven research in bioinformatics. 
A common thread in projects in bioinformatics and computational biology is 
the use of mathematical tools to extract useful information from data 
produced by high-throughput biological techniques such as genome 
sequencing. A representative problem in bioinformatics is the assembly of 
high-quality genome sequences from fragmentary "shotgun" DNA 
sequencing. Other common problems include the study of gene regulation 
using data from microarrays or mass spectrometry. 
 
Software tools 
First generation bioinformatics tools consisted of applications, usually with 
a text-based interface, which performed a specific task well. The 
computational biology tool best-known among biologists is probably 
BLAST, an algorithm for searching large databases of protein or DNA 
sequences. The National Center for Biotechnology Information (NCBI) at 
the National Institutes of Health (NIH) provides a popular web-based 
implementation that searches their massive sequence databases.  
Also fairly early on, due to the amassing of sequence and annotation data, 
keyword search engines which were able to resolve gene and protein 
synonyms were important. Computer scripting languages such as Perl (for 
its regular expressions handling facilities) and Python are often used to 
interface with biological databases and parse output from bioinformatics 
programs written in languages such as C or C++. Communities of 
bioinformatics programmers have set up free open source bioinformatics 
projects to develop and distribute the tools and modules they produce. 
 
As the data sources expanded and diversified, both in content and 
geography, bioinformatics search engines, such as sequence profiling 
tools, to help in finding relevant information from several databases.  
More recently, SOAP-based (Service Oriented Architecture Protocol)  
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interfaces have been developed for a wide variety of bioinformatics 
applications allowing an application running on one computer in one part of 
the world to use algorithms, data and computing resources on servers in 
other parts of the world. A large availability of these SOAP-based 
bioinformatics web services, along with the open source bioinformatics 
collections, lead to the next generation of bioinformatics tools: the 
integrated bioinformatics platform. These tools range from a collection of 
standalone tools with a common data format under a single, slick 
standalone or web-based interface, to integrative and extensible 
bioinformatics workflow development environments. 
One of the crucial steps in Proteomic investigations is the correct use of 
software capable of identifying proteins starting from empirical data. 
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Produced by Matrix Science, Mascot is a powerful search engine, which 
uses mass spectrometry (MS) data to identify proteins from primary 
sequence databases. 
The protein informatics range follows the researcher’s workflow, including 
experiment set-up, 2D gel image analysis, data-mining and MS-based 
protein identification. Generally, to identify an unknown protein the target is 
subjected to protease treatment and the peptide mass fingerprint is 
recorded by a mass spectrometer (MALDI or ESI/MS). The peptide masses 
are then used to perform a pattern search in all available databases, mass 
tolerance is another criterion to increase the stringency in the search. 
Mascot does the job of matching a list of given masses to the MSDB (Mass 
Spec Database), specifically designed for peptide mass searches.  
 
These different search methods can be divided as follows:  
 
• Peptide Mass Fingerprint in which the only experimental data are peptide 
mass values,  
• Sequence Query in which peptide mass data are combined with amino 
acid sequence and composition information. A super-set of a sequence tag 
query,  
• MS/MS Ion Search using uninterpreted MS/MS data from one or more 
peptides.  
 
The first stage of a molecular weight search (MOWSE) peptide-mass 
database (53) is to compare the calculated peptide masses for each entry 
in the sequence database with the set of experimental data. Each 
calculated value which falls within a given mass tolerance of an 
experimental value counts as a match. A molecular weight range for the 
intact protein can be used as a pre-filter. 
Rather than just counting the number of matching peptides, Mowse uses 
empirically determined factors to assign a statistical weight to each 
individual peptide match. The matrix of weighting factors is calculated 
during the database build stage, as follows: 
 27
A frequency factor matrix, F, is created, in which each row represents an 
interval of 100 Da in peptide mass, and each column an interval of 10 kDa 
in intact protein mass. As each sequence entry is processed, the 
appropriate matrix elements fi,j are incremented so as to accumulate 
statistics on the size distribution of peptide masses as a function of protein 
mass. The elements of F are then normalised by dividing the elements of 
each 10 kDa column by the largest value in that column to give the Mowse 
factor matrix M: 
 
 
 
 
After searching the experimental mass values against a calculated peptide 
mass database, the score for each entry is calculated according to: 
 
 
 
 
Where MProt is the molecular weight of the entry and the product term is 
calculated from the Mowse factor elements for each match between the 
experimental data and peptide masses calculated from the entry. 
Mascot incorporates a probability based implementation of the Mowse 
algorithm. The Mowse algorithm is an excellent starting point because it 
accurately models the behaviour of a proteolytic enzyme. By casting the 
Mowse score into a probabilistic framework, we gain a number of additional 
benefits: 
 
   1.  A simple rule can be used to judge whether a result is significant or 
not. 
   2. Different types of matching (peptide masses and fragment ions) can 
be combined in a single search. 
   3. Scores from different searches and on different databases can be 
compared. 
   4. Search parameters can be optimised more readily by iteration.  
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Matches using mass values (either peptide masses or MS/MS fragment ion 
masses) are always handled on a probabilistic basis. The total score is the 
absolute probability that the observed match is a random event. Reporting 
probabilities directly can be confusing. Partly because they encompass a 
very wide range of magnitudes, and also because a "high" score is a "low" 
probability, which can be ambiguous. For this reason, we report scores as -
10*LOG10(P), where P is the absolute probability. A probability of 10-20 
thus becomes a score of 200. 
Given an absolute probability that a match is random, and knowing the size 
of the sequence database being searched, it becomes possible to provide 
an objective measure of the significance of a result. A commonly accepted 
threshold is that an event is significant if it would be expected to occur at 
random with a frequency of less than 5%. This is the value which is 
reported on the master results page. 
The master results page for typical peptide mass fingerprint search reports 
that "Scores greater than 67 are significant (p<0.05)". 
The sequence databases that can be searched on this server are: 
 
• MSDB is a comprehensive, non-identical protein sequence database 
maintained by the Proteomics Department at the Hammersmith Campus of 
Imperial College London. MSDB is designed specifically for mass 
spectrometry applications.  
• NCBInr is a comprehensive, non-identical protein database maintained 
by NCBI for use with their search tools BLAST and Entrez. The entries 
have been compiled from GeneBank CDS translations, PIR, SWISS-
PROT, PRF, and PDB.  
• SwissProt is a high quality, curated protein database. On this server, the 
database has been expanded using the Swissknife VARSPLIC utility. This 
parses the annotation text and creates new entries for any splice variants, 
sequence variants, or sequence conflicts. Original entries have a standard 
Swiss-Prot accession string, such as P13813. New entries, created by 
varsplic, have accession numbers in the form P13744-00-00-01. The title 
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line describes the nature of the differences between the new entry and the 
parent entry.  
 
The result of the search appears in another web page, which automatically 
gives a short description of the protein and offers the option of a longer 
detail analysis of the protein that is matched. 
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1.3 Ageing and Apoptosis 
 
Apoptosis (Greek: apo - from, ptosis - falling) was distinguished from 
traumatic cell death in 1972 by Andrew H. Wyllie while studying tissues 
with electron microscopes (54). He called this process of natural cell death 
apoptosis, from the use of this word in an ancient Greek poem to mean 
"falling off" and its connotations of leaves falling from a tree (54).  
Apoptosis is a process of deliberate life relinquishment by a cell in a 
multicellular organism. It is one of the main types of programmed cell death 
(PCD), and involves an orchestrated series of biochemical events leading 
to a characteristic cell morphology and death. The apoptotic process is 
executed in such a way as to safely dispose of cell corpses and fragments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In contrast to necrosis, which is a form of traumatic cell death that results 
from acute cellular injury, apoptosis is carried out in an orderly process that 
generally confers advantages during an organism's life cycle. For example, 
the differentiation of fingers and toes in a developing human embryo 
requires cells between the fingers to initiate apoptosis so that the digits can 
separate. Between 50 billion and 70 billion cells die each day due to 
Fig .7 A section of mouse liver showing an apoptotic cell indicated by an arrow 
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apoptosis in the average human adult. For an average child between the 
ages of 8 to 14, approximately 20 billion to 30 billion cells die a day. In a 
year, this amounts to the proliferation and subsequent destruction of a 
mass of cells equal to an individual's body weight. 
 
 
 
 
 
 
 
 
 
 
Research on apoptosis has increased substantially since the early 1990s. 
In addition to its importance as a biological phenomenon, defective 
apoptotic processes have been implicated in an extensive variety of 
diseases. Excessive apoptosis causes hypotrophy, such as in ischemic 
damage, whereas an insufficient amount results in uncontrolled cell 
proliferation, such as cancer. 
Apoptosis can occur when a cell is damaged beyond repair, infected with a 
virus, or undergoing stress conditions such as starvation or ageing. DNA 
damage from ionizing radiation or toxic chemicals can also induce 
apoptosis via the actions of the tumour-suppressing gene p53. The 
"decision" for apoptosis can come from the cell itself, from the surrounding 
tissue, or from a cell that is part of the immune system. In these cases 
apoptosis functions to remove the damaged cell, preventing it from sapping 
further nutrients from the organism, or to prevent the spread of viral 
infection. 
Apoptosis also plays a role in preventing cancer; if a cell is unable to 
undergo apoptosis, due to mutation or biochemical inhibition, it can 
continue dividing and develop into a tumour. For example, infection by 
papillomaviruses causes a viral gene to interfere with the cell's p53 protein, 
an important member of the apoptotic pathway. This interference in the 
Fig.8 Incomplete 
differentiation in 
two toes 
(syndactyly) due 
to lack of 
apoptosis 
 32
apoptotic capability of the cell plays a critical role in the development of 
cervical cancer. 
 
 
 
 
1.3.1Homeostasis 
 
In adult organism, the number of cells is kept relatively constant through 
cell death and division. Cells must be replaced when they become 
diseased or malfunctioning; but proliferation must be compensated by cell 
death (55). This balancing process is part of the homeostasis required by 
living organisms to maintain their internal states within certain limits. Some 
scientists have suggested homeodynamics as a more accurate term (56, 
57). The related term allostasis reflects a balance of a more complex 
nature by the body. 
Homeostasis is achieved when the rate of mitosis (cell division) in the 
tissue is balanced by cell death. If this equilibrium is disturbed, one of two 
potentially fatal disorders occurs: 
 
? The cells are dividing faster than they die, effectively developing a 
tumour.  
? The cells are dividing slower than they die, which results in a 
disorder of cell loss.  
? The organism must orchestrate a complex series of controls to 
keep homeostasis tightly controlled, a process which is ongoing for the life 
of the organism and involves many different types of cell signalling. 
Impairment of any one of these controls can lead to a diseased state: for 
example, deregulation of hedgehog signalling has been implicated in 
several forms of cancer. The hedgehog pathway, which conveys an anti-
apoptotic signal, has been found to be activated in pancreatic 
adenocarcinoma tissues. 
 
Programmed cell death is an integral part of both plant and animal tissue 
development. Development of an organ or tissue is often preceded by the 
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extensive division and differentiation of a particular cell, the resultant mass 
is then "pruned" into the correct form by apoptosis. Unlike cellular death 
caused by injury, apoptosis results in cell shrinkage and fragmentation. 
This allows the cells to be efficiently phagocytosed and their components 
reused without releasing potentially harmful intracellular substances into 
the surrounding tissue. 
During development, apoptosis is tightly regulated and different tissues use 
different signals for inducing apoptosis. In birds, bone morphogenetic 
proteins (BMP) signaling is used to induce apoptosis in the interdigital 
tissue. In Drosophila flies, steroid hormones regulate cell death. 
Developmental cues can also induce apoptosis, such as the sex-specific 
cell death of hermaphrodite specific neurons in C. elegans males through 
low TRA-1 transcription factor activity (TRA-1 helps prevent cell death). 
The process of apoptosis is controlled by a diverse range of cell signals 
which may originate either extracellularly (extrinsic inducers) or 
intracellularly (intrinsic inducers). Extracellular signals may include 
hormones, growth factors, nitric oxide (58, 59, 60, 61) or cytokines, and 
therefore must either cross the plasma membrane or transduce to effect a 
response. These signals may positively or negatively induce apoptosis; in 
this context the binding and subsequent initiation of apoptosis by a 
molecule is termed positive, whereas the active repression of apoptosis by 
a molecule is termed negative. 
Intracellular apoptotic signalling is a response initiated by a cell in response 
to stress, and may ultimately result in cell suicide. The binding of nuclear 
receptors by glucocorticoids, heat, radiation, nutrient deprivation, viral 
infection and hypoxia are all factors which can lead to the release of 
intracellular apoptotic signals by a damaged cell (62). A number of cellular 
components, such as poly ADP ribose polymerase, may also help regulate 
apoptosis (63). 
Before the actual process of cell death is carried out by enzymes, apoptotic 
signals must be connected to the actual death pathway by way of 
regulatory proteins. This step allows apoptotic signals to either culminate in 
cell death, or be aborted should the cell no longer need to die. Several 
proteins are involved, however two main methods of achieving regulation 
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have been identified; targeting mitochondria functionality, or directly 
transducing the signal via adapter proteins to the apoptotic mechanisms. 
The whole preparation process requires energy and functioning cell 
machinery. 
 
 
 
1.3.2 Mitochondrial regulation 
The mitochondria are essential to multicellular life, without them a cell 
ceases to respire aerobically and quickly dies - a fact exploited by some 
apoptotic pathways. Apoptotic proteins which target mitochondria affect 
them in different ways; they may cause mitochondrial swelling through the 
formation of membrane pores, or they may increase the permeability of the 
mitochondrial membrane and cause apoptotic effectors to leak out (64). 
There is also a growing body of evidence which indicates that nitric oxide 
(NO) is able to induce apoptosis by helping to dissipate the membrane 
potential of mitochondria and therefore make it more permeable (65). 
Fig 9. Mitochondrial regulation 
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Mitochondrial proteins known as SMACs (second mitochondria-derived 
activator of caspases) are released into the cytosol following an increase in 
permeability. SMAC binds to inhibitor of apoptosis proteins (IAPs) and 
inhibits them, preventing the IAPs from arresting the apoptotic process and 
therefore allowing apoptosis to proceed. IAP also normally suppresses the 
activity of a group of cysteine proteases called caspases (66), which carry 
out the degradation of the cell, therefore the actual degradation enzymes 
can be seen to be indirectly regulated by mitochondrial permeability. 
 
Cytochrome c is also released from mitochondria due to increased 
permeability of the outer mitochondrial membrane, and serves a regulatory 
function as it precedes morphological change associated with apoptosis 
(67). Once cytochrome c is released it binds with Apaf-1 and ATP, which 
then bind to pro-caspase-9 to create a protein complex known as an 
apoptosome. The apoptosome cleaves the pro-caspase to its active form 
of caspase-9, which in turn activates the effector caspase-3. 
 
The mitochondrial permeability is itself subject to regulation by various 
proteins, such as those encoded by the mammalian Bcl-2 family of anti-
apoptotic genes, the homologs of the ced-9 gene found in C. elegans (68). 
Bcl-2 proteins are able to promote or inhibit apoptosis by either direct 
action on mitochondrial permeability, or indirectly through other proteins. 
Importantly, the actions of some Bcl-2 proteins are able to halt apoptosis 
even if cytochrome c has been released by the mitochondria (67). 
 
Two important examples of the direct initiation of apoptotic mechanisms in 
mammals include the TNF-induced (tumour necrosis factor) model and the 
Fas-Fas ligand-mediated model, both involving receptors of the TNF 
receptor (TNFR) family (69) coupled to extrinsic signals. 
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TNF is a cytokine produced mainly by activated macrophages, and is the 
major extrinsic mediator of apoptosis. Most cells in the human body have 
Fig.10 Overview 
of TNF signaling 
in apoptosis, an 
example of 
direct signal 
transduction 
Fig. 11 Overview 
of Fas signaling in 
apoptosis, an 
example of direct 
signal transduction 
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two receptors for TNF: TNF-R1 and TNF-R2. The binding of TNF to TNF-
R1 has been shown to initiate the pathway that leads to caspase activation 
via the intermediate membrane proteins TNF receptor-associated death 
domain (TRADD) and Fas-associated death domain protein (FADD) (70). 
Binding of this receptor can also indirectly lead to the activation of 
transcription factors involved in cell survival and inflammatory responses 
(71). The link between TNF and apoptosis shows why an abnormal 
production of TNF plays a fundamental role in several human diseases, 
especially in autoimmune diseases. 
 
The Fas receptor (also known as Apo-1 or CD95) binds the Fas ligand 
(FasL), a transmembrane protein part of the TNF family (72). The 
interaction between Fas and FasL results in the formation of the death-
inducing signaling complex (DISC), which contains the FADD, caspase-8 
and caspase-10. In some types of cells (type I), processed caspase-8 
directly activates other members of the caspase family, and triggers the 
execution of apoptosis. In other types of cells (type II), the Fas-DISC starts 
a feedback loop that spirals into increasing release of pro-apoptotic factors 
from mitochondria and the amplified activation of caspase-8 (73). 
Following TNF-R1 and Fas activation in mammalian cells a balance 
between pro-apoptotic (BAX [17], BID, BAK, or BAD) and anti-apoptotic 
(Bcl-Xl and Bcl-2) members of the Bcl-2 family is established. This balance 
is the proportion of pro-apoptotic homodimers that form in the outer-
membrane of the mitochondrion. The pro-apoptotic homodimers are 
required to make the mitochondrial membrane permeable for the release of 
caspase activators such as cytochrome c and SMAC. Control of pro-
apoptotic proteins under normal cell conditions of non-apoptotic cells is 
incompletely understood, but it has been found that a mitochondrial outer-
membrane protein, VDAC2, interacts with BAK to keep this potentially-
lethal apoptotic effector under control (74). When the death signal is 
received, products of the activation cascade displace VDAC2 and BAK is 
able to be activated. 
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1.3.3 Execution 
 
Although many pathways and signals lead to apoptosis, there is only one 
mechanism which actually causes the death of the cell in this process; after 
the appropriate stimulus has been received by the cell and the necessary 
controls exerted, a cell will undergo the organised degradation of cellular 
organelles by activated proteolytic caspases. A cell undergoing apoptosis 
shows a characteristic morphology that can be observed with a 
microscope: 
 
Cell shrinkage and rounding due to the breakdown of the proteinaceous 
cytoskeleton by caspases.  
The cytoplasm appears dense, and the organelles appear tightly packed.  
Chromatin undergoes condensation into compact patches against the 
nuclear envelope in a process known as pyknosis, a hallmark of apoptosis 
(75).  
The nuclear envelope becomes discontinuous and the DNA inside it is 
fragmented in a process referred to as karyorrhexis. The nucleus breaks 
into several discrete chromatin bodies or nucleosomal units due to the 
degradation of DNA (76).  
The cell membrane shows irregular buds known as blebs.  
The cell breaks apart into several vesicles called apoptotic bodies, which 
are then phagocytosed.  
Apoptosis progresses quickly and its products are quickly removed, making 
it difficult to detect or visualize. During karyorrhexis, endonuclease 
activation leaves short DNA fragments, regularly spaced in size. These 
give a characteristic "laddered" appearance on agar gel after 
electrophoresis. Tests for DNA laddering differentiate apoptosis from 
ischemic or toxic cell death.  
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1.3.4 Removal of dead cells  
 
Dying cells that undergo the final stages of apoptosis display phagocytotic 
molecules, such as phosphatidylserine, on their cell surface. 
Phosphatidylserine is normally found on the cytosolic surface of the plasma 
membrane, but is redistributed during apoptosis to the extracellular surface 
by a hypothetical protein known as scramblase (77). These molecules 
mark the cell for phagocytosis by cells possessing the appropriate 
receptors, such as macrophages (78). Upon recognition, the phagocyte 
Fig 12. Execution of Apoptosis and dead cells removal 
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reorganizes its cytoskeleton for engulfment of the cell. The removal of 
dying cells by phagocytes occurs in an orderly manner without eliciting an 
inflammatory response. 
 
  
 
The many different types of apoptotic pathways contain a multitude of 
different biochemical components, many of them not yet understood. As a 
pathway is more or less sequential in nature it is a victim of causality; 
removing or modifying one component leads to an effect in another. In a 
living organism this can have disastrous effects, often in the form of 
disease or disorder. A discussion of every disease caused by modification 
of the various apoptotic pathways would be impractical, but the concept 
overlying each one is the same: the normal functioning of the pathway has 
been disrupted in such a way as to impair the ability of the cell to undergo 
normal apoptosis. This results in a cell which lives past its "use-by-date" 
and is able to replicate and pass on any faulty machinery to its progeny, 
increasing the likelihood of the cell becoming cancerous or diseased. 
 
A recently described example of this concept in action can be seen in the 
development of a lung cancer called NCI-H460 (79). The X-linked inhibitor 
of apoptosis protein (XIAP) is overexpressed in cells of the H460 cell line. 
XIAPs bind to the processed form of caspase-9, and suppress the activity 
of apoptotic activator cytochrome c, therefore overexpression leads to a 
decrease in the amount of pro-apoptotic agonists. Consequently, the 
balance of anti-apoptotic and pro-apoptotic effectors is upset in favour of 
the former and the damaged cells continue to replicate despite being told 
to die. 
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1.3.5Yeast and metazoan ageing 
 
Yeast provides a simple and powerful 
model for the study of cellular complex 
mechanisms such as apotosis caused by 
ageing, due to the presence of simplified 
regulatory pathways, comparing to more 
complex organisms, such as Homo 
sapiens.  
 
 
 
 Fig 13 simplified pathways in yeast 
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In yeast, two different forms of aging processes are studied: one is mother 
cell-specific aging  in which only the mother cell ages, while the daughter 
cell resets the clock to zero. 
 Age in this case is measured by cell generations, not by calendar time. 
The daughter cells remain in the stem cell pool while the other cell has 
made the first step towards differentiation. Resetting the clock is also 
known as ‘‘rejuvenation’’, a process which is absolutely necessary for 
survival of the yeast strain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The second process of aging that can be studied in yeast is chronological 
aging of postmitotic cells. This aging process simply is the process of 
deterioration and loss of viability of cells during stationary phase. Again, 
like in mother cell-specific replicative aging, chronological aging is a 
process of genetically controlled cell differentiation. To give an example, 
the cell wall of stationary cells undergoes genetically controlled structural 
changes and remodelling. The chronological lifespan measures the ability 
of stationary (G0) phase yeast cultures to maintain viability over time (80, 
81, 82). It is the a model of ageing in nondividing cells. (80,81,82,83). An 
increase in intracellular oxidative stress, in ROS and in “death factors” 
Fig. 14 Scheme of yeast ageing forms 
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seems to be common to the two aging processes as reported by many 
authors.  
Reactive oxygen species generated by aerobic metabolism cause oxidative 
damage to cell macromolecules such as proteins, DNA and lipids inducing 
structure alteration and in many cases loss of function. It is now widely 
accepted that accumulation of these dysfunctional molecules during 
lifespan of the cell plays a key role in ageing process and degenerative 
diseases. 
 
 
 
 
 
 
 
 
 
 
 
Fig.15 effect of H2O2 on cellular macromolecules 
 
 
 
Harman’s “free radical theory of aging” is now fifty years old; today 
although ROS are believed as the major cause of ageing many questions 
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remains opened. In particular is not clear the relationship between 
metabolism rate and ROS production. Furthermore, although many 
molecules are found in oxidized state during cell senescence, is not clear 
which are the relevant targets of oxidation and how their modification can 
affect lifespan.  
In both forms of ageing, the terminal yeast cells execute apoptosis. This 
may elucidate some questions about the oxygen theory of ageing in 
mammalian cells. The involvement of oxygen toxicity in the ageing 
processes of cells as widely divergent as human and yeast leads to the 
proposal to use the powerful system of yeast molecular genetics to study 
the role of oxygen toxicity as a mechanism of ageing. 
It has became clear through recent studies of yeast and human cells, that 
apoptosis is not only a mechanism to prevent ageing of a tissue by 
removing irreversibly damaged cells which can then be replaced by 
regeneration.  
Yeast cells are also an excellent system to test other current theories of 
ageing. Prominent among them are the theory according to which an 
ageing signal is produced by critically short telomeres and the theory 
according to which unrepaired DNA damage leads to premature ageing 
and apoptosis. 
In non-dividing cells, essential components that become damaged cannot 
be diluted out through cell division but must, of necessity, be turned over 
and renewed. By elevating stress resistances, many of the activities 
needed for such renewal should be elevated with commensurate reduction 
in the steady-state levels of damaged cell components. Therefore, 
chronological lifespan in particular might be expected to relate to stress 
resistance. For yeast to attain a full chronological lifespan requires the 
expression of the general stress response. It is more important, though, 
that the cells should be efficiently adapted to respiratory maintenance, 
since it is culture grown to stationary phase on respiratory media that 
usually display the longest chronological lifespan. For this reason, 
respiration-adapted cells potentially provide a better model of chronological 
ageing than cultures pre-grown on glucose. (84) 
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2. Aim of the project 
 
The proteomic approach offers all the instruments to deeply understand the 
mechanisms of this phenomenon. The high capacity of the analytical 
technique used in proteomics to resolve complex mixture of proteins 
extracted from a cell and the very sensitive techniques used to identify 
them, led in the last few years to a better understanding of apoptosis. 
 
A procedure for detecting proteins that contain oxidation-sensitive cysteine 
residues, as a means to study protein oxidation from different growth 
conditions in yeast cells, was the main goal of this project.  
The procedure is based on the fact that biotin-conjugated iodoacetamide 
(BIAM)  selectively 
reacts with free 
thiols in cysteine 
residues ( Fig.16).  
The decrease in 
proteins labelling 
with BIAM can be 
monitored by 
western blot 
analysis.  
Thiol (SH) groups play a broad range of roles in the cell, since their redox 
state can affect the activity and the structure of enzymes, receptors and 
transcription factors.  
 
 
 
 
 
 
 
 
BIAM 
Fig. 16 Reaction between BIAM and cysteine thiol group 
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 In this study we evaluated the redox state of proteins combining a 
selective method for labelling proteins containing reduced cysteine 
residues and mono/two dimensional electrophoresis followed by mass 
spectrometry. In fact cysteine residues can react with ROS and can 
function as detector of redox status of the cells. In particular we compared 
yeast cells exponentially growing with cells during chronological ageing. 
The experiments were performed in complete synthetic medium (SC) 
containing three different carbon source: glucose 2%, glucose 0,5% and 
3% glycerol.  SC plus 2% glucose is the standard medium used from many 
authors to  study the chronological aging features. In this condition yeast 
cells initially obtain energy through fermentation pathway and 
approximately after 10 hours, when the glucose concentration reaches very 
low level, yeasts switch to respiration pathway. This switch is called 
“diauxic shift” and then yeast enter in the post-diauxic phase. In this phase 
cells grow slowly until about 48 hours and then stop dividing but the 
metabolic rate remain high until approximately one week (80). SD plus 
0,5% glucose is the medium used to mimic caloric restriction; in this 
condition yeast cells show an increase of life span probably through a 
decrease in ROS production although the mechanism involved in this 
reduction is still debated. For the fist time we also tested a role of a pour 
fermentable carbon source as glycerol on yeast chronological aging.  
 
 
 
 
 
 
 
 
 
 
 
  
 47
 
3.Matherial and Methods  
The strain used in this study is W303-A (MATa leu2-3,112ura3-1 trp1-92 
his3-11, 15 ade2-1 can1, 100, GAL SUC mal). Yeast cells were grown at 
30°C in complete SC medium (0,17% yeast nitrogen base without 
aminoacid)  supplemented with complete dropout and a four-fold excess of 
leucine, tryptophan, adenine, histydine, and uracil. These supplements 
were added in excess to prevent any growth limitation due to the 
auxotrophies of the W303. 2% glucose, 0,5% glucose or 3% glycerol were 
used as carbon sources. YEPD solid medium (1% yeast extract, 2% 
peptone, 2% w/v glucose, 2% w/v agar used as carbon sources) was used 
to perform viability assay.  
 
Cells viability assay  
Cell viability was measured by plating serial dilution of treated and 
untreated cells on YEPD plates. The percentage of colony-forming units 
(c.f.u.) of cells treated was obtained by relating the c.f.u. counts of treated 
cells to those untreated which were considered to be 100%. Viability is 
defined as the ability of a single cell to form a colony within 2 days.  
 
Cystein residues labelling  
Cells grown in SC medium supplemented with glucose 2%, glucose 0,5% 
or 3% glycerol  were harvested in exponential phase (0,8 O.D./ml) and 
after 24, 48, 72 hours and one week. For 1D electrophoresis 1 O.D. of cells 
were broken in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% 
NP-40, 1% Sodium deoxycholate and 0.1 % SDS) containing 40 μM 
biotinylated iodoacetamide, BIAM (Molecular Probes) with glass beads in a 
Fastprep instrument (Savant) and protein extracts were clarified by 
centrifugation at 8000g for 10 minutes. For 2D electrophoresis cells were 
broken 8M urea, 4% CHAPS, 200 μM BIAM and Tris-HCl pH7.  In both 
cases the labelling reaction was stopped with 10mM DTT.    
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Affinity chromatography 
After cystein residues labelling yeast extract sample was submitted to a 
purification protocol using immobilized avidin resin. This is a 
chromatographic procedure based on affinity between avidin and biotin: 
proteins labelled with BIAM binds resin making their isolation possible. 
Resin had been equilibrated by 0,1 M phosphate, 0,15 M sodium chloride, 
pH7,2 buffer washing . Cellular extracts had been incubated with resin over 
night at 4°C. After washing procedure by washing buffer, in order to 
remove non BIAM containing proteins, samples were eluted by 30% 
Acetonitrile, 0,4% TFA 
 
Electrophoresis and western blot.  
For 1D electrophoresis labelled samples were prepared as previously 
described,  separated on SDS-PAGE and transferred on PVDF membrane 
(Millipore). 2Delectrophoresis IEF (first dimension) was carried out on non-
linear wide-range immobilized pH gradients (pH 3-10; 18 cm long IPG 
strips; GE Healthcare, Uppsala, Sweden) and achieved using the Ettan 
IPGphor system (GE Healthcare, Uppsala, Sweden). Analytical-run IPG-
strips were rehydrated with 60μg of total proteins in 350μl of lysis buffer 
and 0,2% (v/v) carrier ampholyte for 1h at 0 V and for 8h at 30 V, at 16°C. 
The strips were then focused according to the following electrical 
conditions at 16°C: 200 V for 1h, from 300 V to 3500 V in 30 min, 3500 V 
for 3h, from 3500 V to 8000 V in 30 min, 8000 V until a total of 80000 Vh 
was reached. For preparative gels 400μg of total proteins were used. After 
focusing, analytical and preparative IPG strips were equilibrated for 12 min 
in 6 M urea, 30% (V/V) glycerol, 2% (w/V) SDS, 0.05 M Tris-HCl, pH 6.8, 
2% (w/V) DTE, and subsequently for 5 min in the same urea/SDS/Tris 
buffer solution but substituting the 2% (w/V) DTE with 2.5% (w/V) 
iodoacetamide. The second dimension was carried out on 9-16% 
polyacrylamide linear gradient gels (18 cm x 20 cm x 1.5 mm) at 40 mA/gel 
constant current and 10°C until the dye front reached the bottom of the gel, 
according to Laemmli et al and Hochstrasser et al. Analytical gels were 
stained with ammoniacal silver nitrate as previously described [ref]; while 
MS-preparative gels were stained with colloidal comassie. For western blot 
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of 2D gels 150 μg of total proteins were transferred on PDVF membrane 
overnight at 4°C using a constant current of 100mA.  
In all cases the blots were incubated at least four hours with blocking buffer 
(PBS, 2% non-fat dry milk, 0.1% v/v Tween-20). Biotinylated proteins were 
detected incubating PVDF membrane with streptavidine conjugated horse 
radish peroxidase (Biorad). The chemiluminescence immunodetection 
system (GE Healthcare) was used for signal development.
         Image analysis  
Gels and western blot imagines were acquired with an Epson expression 
1680 PRO scanner. Computer-aided 2-D image analysis was carried out 
using the MELANIE 4.0 software (GeneBio, Geneva, Switzerland). Relative 
spot volumes (%V) (V=integration of OD over the spot area; %V = V single 
spot/V total spot) were used for quantitative analysis in order to decrease 
experimental errors. The normalized intensity of spots on three replicate 2-
D gels was averaged and standard deviation was calculated for each 
condition. A two-tiled non-paired Student’s T-test was performed using 
ORIGIN 6.0 (Microcal Software, Inc.) to determine if the relative change 
was statistically significant. Reported pI and Mr (Da) values were 
experimentally determined by comigration with human serum as internal 
standard.  
 
Protein identification by Mass Spectrometry 
TPCK-treated Trypsin, dithiothreitol, and alfa-cyano-4-hydroxycinnamic 
acid were from Sigma-Aldrich (St. Louis, MO, USA). All other reagents and 
solvents were of the highest purity available from Carlo Erba (Milan, Italy). 
 
In situ digestion 
The analysis was performed on the Comassie blue-stained spots excised 
from gels. The excised spots were washed first with ACN and then with 
0.1M ammonium bicarbonate. Protein samples were reduced by incubation 
in 10mM dithiothreitol (DTT) for 45 min at 56°C. The cysteines were 
alkylated by incubation in 5mM iodoacetamide for 15 min at room 
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temperature in the dark. The gel particles were then washed with 
ammonium bicarbonate and ACN. 
Enzymatic digestion was carried out with trypsin (12.5ng/µl) in 50mM 
ammonium bicarbonate pH 8.5 at 4°C for 4 hours. The buffer solution was 
then removed and a new aliquot of the enzyme/buffer solution was added 
for 18 hours at 37°C. A minimum reaction volume, enough for the complete 
rehydratation of the gel was used. Peptides were then extracted washing 
the gel particles with 20mM ammonium bicarbonate and 0.1% TFA in 50% 
ACN at room temperature and then lyophilised. 
 
MALDI-TOF Mass spectrometry 
Positive Reflectron MALDI spectra spectra were recorded on a Voyager 
DE STR instrument (Applied Biosystems, Framingham, MA). The MALDI 
matrix was prepared by dissolving 10 mg of alpha cyano in 1 mL of 
acetonitrile / water (90:10 v/v). Typically, 1 uL of matrix was applied to the 
metallic sample plate and 1 uL of analyte was then added. Acceleration 
and reflector voltages were set up as follow: target voltage at 20 kV, first 
grid at 95% of target voltage, delayed extraction at 600 ns to obtain the 
best signal-to-noise ratios and the best possible isotopic resolution with 
multipoint external calibration using peptide mixture purchased from 
Applied Biosystems. Each spectrum represents the sum of 1500 laser 
pulses from randomly chosen spots per sample position. 
Raw data were analyzed using the computer software provided by the 
manufacturers and are reported as monoisotopic masses. 
 
nanoLC Mass Spectrometry 
A mixture of peptide solution was analysed by LCMS analysis using a 
4000Q-Trap (Applied Biosystems) coupled to an 1100 nano HPLC system 
(Agilent Technologies). The mixture was loaded on an Agilent reverse-
phase pre-column cartridge (Zorbax 300 SB-C18, 5x0.3 mm, 5 μm) at 10 
μl/min (A solvent 0.1% formic acid, loading time 5 min). Peptides were 
separated on a Agilent reverse-phase column (Zorbax 300 SB-C18, 150 
mm X 75μm, 3.5 μm), at a flow rate of 0.3 μl/min with a 0% to 65% linear 
gradient in 60 min (A solvent 0.1% formic acid, 2% ACN in MQ water; B 
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solvent 0.1% formic acid, 2% MQ water in ACN). Nanospray source was 
used at 2.5 kV with liquid coupling, with a declustering potential of 20 V, 
using an uncoated silica tip from New Objectives (O.D. 150 µm, I.D. 20 µm, 
T.D. 10 µm). Data were acquired in information-dependent acquisition 
(IDA) mode, in which a full scan mass spectrum was followed by MS/MS of 
the 5 most abundant ions (2 s each). In particular, spectra acquisition of 
MS-MS analysis was based on a survey Enhanced MS Scan.(EMS) from 
400 m/z to 1400 m/z at 4000 amu/sec. This scan mode was followed by an 
Enhanced Resolution experiment (ER) for the five most intense ions and 
then MS2 spectra (EPI) were acquired using the best collision energy 
calculated on the bases of m/z values and charge state (rolling collision 
energy) from 100 m/z to 1400 m/z at 4000 amu/sec. Data were acquired 
and processed using Analyst software (Applied Biosystems).  
 
 
MASCOT analysis 
 Spectral data were analyzed using Analyst software (version 1.4.1) and 
MS-MS centroid peak lists were generated using the MASCOT.dll script 
(version 1.6b9). MS-MS centroid peaks were threshold at 0.1% of the base 
peak. MS/MS spectra having less than 10 peaks were rejected. MS/MS 
spectra were searched against NCBInr database using the licensed 
version of Mascot 2.1 version (Matrix Science), after converting the 
acquired MS-MS spectra in mascot generic file format. The Mascot search 
parameters were: taxonomy Saccharomices cerevisiae; allowed number of 
missed cleavages 2; enzyme trypsin; variable post-translational 
modifications, methionine oxidation, pyro-glu N-term Q; peptide tolerance 
200ppm and MS/MS tolerance 0.5 Da; peptide charge, from +2 to +3 and 
top 20 protein entries. Spectra with a MASCOT score <25 having low 
quality were rejected.  The score used to evaluate quality of matches for 
MS-MS data was higher than 30. However, spectral data were manually 
validated and contained sufficient information to assign peptide sequence 
and  BIAM labelled Cysteine.  
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Confocal microscopy analysis and mitochondria function assay  
 
Cells grown in SD complete medium were harvested at the indicated time. 
1 O.D. of cells were washed twice in 10 mM HEPES buffer containing 5% 
glucose and resuspended in the same buffer with 100nM Rhodamine B 
hexyl  ester or 2,5 μM dihydrorhodamine 123 (both 123  from Molecular 
Probes) in order to evidence  mitochondrion structure and ROS production 
respectively. The cells were incubated at 30° C in the dark for 45 minutes 
for rhodamine B hexyl  ester staining and for 2 hours for dihydrorhodamine 
123 staining. The treated cells washed twice in 10mM Hepes buffer, 5% 
glucose were visualized on Laika  
Cytochrome spectra and respiration 
Each cytochrome is characterized by a peak of absorption at a specific 
wavelength: cytochorme aa3 = 602 nm (cytochrome c oxidase); 
cytochrome b = 560 nm; cytochrome c = 550 nm. Differential spectra 
between reduced and oxidized cells were recorded at room temperature, 
using a Cary 219 spectrophotometer, following the absorption of cellular 
samples from 630 nm to 540 nm. The height of each peak relative to the 
baseline of each spectrum is an index of cytochrome content (Dequard et 
al., 1980). 
Oxygen uptake rate was measured at 30°C using a Hansatech Oxygraph. 
100µl of a suspension of cells were added in the respiration buffer (0.1M K-
Phthalate, pH 5.0). The rate of decreasing in oxygen content related to the 
amount of cells (dry weight) is an index of the respiratory ability of the 
analysed strain (Foury, 1989). 
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4. RESULTS 
 
4.1 Calorie restriction and glycerol increase cronological life span. 
S. cerevisiae cells were grown in complete synthetic medium (SC) 
containing three different carbon source: 2% glucose, 0.5% glucose and 3% 
glycerol. SC plus 2% glucose (SCD) constitutes the standard medium used 
to study chronological ageing features (2), whereas the reduction of glucose 
content in the media from 2% to 0.5% is a model for caloric restriction (CR) 
in yeast (12). When the glucose level is limited, respiration is preferred to 
fermentation and carbon is directed to the mitochondria increasing electrons 
transport and respiration. Finally, the non-fermentable substrate glycerol 
(SCG) drives the energy metabolism toward respiration as the unique way 
to produce ATP.  
 
 
 
 Fig17. Cell viability on different carbon sources. The percentage of 
colony-forming units (c.f.u.) of yeast cells was obtained by relating the c.f.u. counts of cells 
during ageing to those at the beginning of stationary phase which were considered to be 
100%. The graphic is representative of three different independent experiment. 
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The ability of 3% glycerol (SCG) and/or caloric restriction (CR) to extend 
chronological lifespan of yeast cells was firstly examinated (Fig. 17). Cell 
viability on different carbon sources was determined by measuring the 
percentage of colony-forming units (c.f.u.) of yeast cells during ageing. 
Figure 17 shows that the viability of yeast strains varies dramatically in 
different media conditions. When S. cerevisiae was grown in SCD, less than 
10% of the cells were viable after 10 days whereas more than 50% of the 
cells were still viable after the same period when the cells were cultured in 
CR. Moreover, growing on a respiratory substrate as SCG yielded more 
than 40% of the yeast cells viable after 10 days.  
According to these results, yeast cells grown for 72h (3 days) were selected 
as a model for chronologically aged cells during all the experiments as in 
these conditions the yeast cells in late stationary growth fase (non-dividing 
cells) gradually senesce but they are still alive. 
 
4.2 ROS production, and mitochondria phenotypes during chronological 
aging in different carbon source.  
 
Cellular ageing results in oxidative stress caused by the accumulation of 
oxygen-containing free radicals (81,82,83,84). 
 The relationship between ageing and oxidative stress was then verified in 
the three different carbon sources (SCD, SCG and CR) by evaluating the 
amount of ROS production with dihydrorhodamine (DHR) 123 during the 
growth. DHR123 is a nonfluorescent dye able to enter into the cells where it 
is oxidized by oxidative species or the cellular redox system to the 
fluorescent rhodamine 123 that accumulates in the mitochondrial 
membranes.  
 
 
 
 
 
 
 
Rhodamine B 
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A relatively low and comparable ROS production was observed in yeast 
cells in the exponential growth phase independently from the different 
carbon source (data not shown). However, the growth medium greatly 
affected ROS production during ageing. When the ROS level was compared 
in chronologically aged cells (72h), oxidation of DHR resulted to be 
considerably higher in yeast grown on SCD in comparison to CR or SCG. 
Figure 18 panel A shows that about 70% of the cells were stained with 
fluorescent DHR after 72h of growth in SCD indicating a high level of ROS 
production. On the contrary, the percentage of fluorescent cells after the 
same period of growth was less then 20% when CR or SCG were used as  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.18 Panel A 
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used as carbon source, suggesting a reduced level of ROS accumulation.  
 
Since mitochondria constitute the major source of ROS generation in the 
cell, the morphology of mitochondria in aged cells was analyzed using the 
plasmid pYX232-mtGFP that allows GFP to be specifically located into the 
organelles. Figure 18B shows that during ageing the morphology of SCD 
mitochondria became similar to those of CR and SCG (magnified images in 
Fig 18B) according to the switch to a derepressed state characteristic of low  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2% glucose                    0.5%glucose                     3%glycerol 
 
72h 
Exponential phase 
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glucose level after 72h of growth. It is interesting to note that the number of 
GFP-labelled yeast cells drastically decreased during ageing in SCD in 
comparison with the other two conditions, as shown in Fig. 18B. This 
decrease is clear just at 24 hours likely indicating that the aged cells in SCD 
are not proficient to retain or to correctly reproduce functional mitochondria.  
Moreover, growth conditions differently affected the mitochondria structure. 
In the exponential phase, yeast cells growing on CR and particularly on 
SCG showed a large number of small mitochondria whereas few, large and 
branched organelles (described as mitochondria reticula) were detected in 
cells growing in a reach glucose medium. These observations confirmed 
previous data from by Vissel et al. who extensively analysed the reticula 
morphology in different growth conditions Fleury et al., 2002. 
 
4.3 O2 consumption and cytochrome content during cronological life span in 
different carbon source 
As yeast cells grown on different carbon sources showed different ROS 
release, the ability of the yeast to respire in the different conditions was 
measured by evaluating the rate of mitochondrial oxygen consumption after 
24 and 72 hours of growth. As shown in Fig. 19A, at 24 hours similar values 
of oxygen consumption rate were observed for the cells independently from 
the growth conditions. However, after 72 hours of growth the oxygen 
consumption decreased to 30% for the cells in SCD while a lower decrease  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.19A 
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Fig. 19 A. O2 consumption in SCD (black bars), CR (squared bars) and 
SCG (white bars) growth conditions. Oxygen uptake rate was measured at 
30°C using a Hansatech Oxygraphas described in Material and Methods. 
After 72 hours of growth O2 consumption in SCG and CR is significant 
higher than in SCD. 
 
 
was observed for those in SCG and CR with a reduction of about 50% of the 
consumption rate measured at 24 hours. 
The decrease in respiration observed in yeast grown in 2% glucose might 
have been related to an alteration on the amount of the various 
cytochromes. A linear relationship between the respiratory rate and the 
amount of each kind of cytochrome, in fact, exists indicating that respiratory 
rate is mostly controlled by the amount of respiratory chain components. 
The mitochondrial cytochromes content in the strains under consideration 
was then assessed in different carbon sources and growth phases by 
spectroscopic analyses. As shown in Fig. 19B, at 24 h the cytochromes a, 
a3, b, c1 and c are present in the yeast grown in all the medium analyzed. 
However, the amount of cytochrome c was lower in the yeast grown in SCD 
in comparison to SCG and CR, with this deficiency increasing at 72h as 
indicated by the relative heights of the peaks corresponding to the 
cytochrome c, c1 and b. The cytochrome c deficiency suggests a non 
proper functioning of mitochondria in the presence of 2% glucose both at 
24h and in chronological ageing.  
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Fig.19B Oxidized versus reduced cytochrome spectra of W303 strain 
cultured in SDC medium supplemented with the indicated carbon source 
after (A) 24h and (B) 72h of grown at 28°C. The peaks at 550, 560 and 602 
nm (vertical bars) correspond to cytochromes c, b and aa3, respectively. 
The height of each peak relative to the baseline of each spectrum is an 
index of cytochrome content. 
 
   
 
4.4 Detection of oxidation-sensitive cysteine during chronological aging in 
different carbon sources.  
The redox status of cysteine residues might be involved in the regulation of 
protein function but it also represents a signal of oxidative damage. ROS 
are able to oxidize cysteine residues in protein to cysteine sulfenic acid (P-
SOH) or disulfide that are readily reduced back to reduced cysteine by 
cellular reductants. These modifications could play a regulative role, i.e. 
 60
modification of enzyme activity or protein localization, and in this view the 
oxidation is not a negative or harmful event.  
Oxidation of protein cysteines in yeast cells grown in different conditions 
was then investigated by using the BIAM [N-(Biotinoyl)-
N’(iodoacetyl)ethylenediamine] labelling protocol [11]. This procedures is 
based on the ability of BIAM to react with reduced cysteine residues 
whereas oxidized Cys are not modified by the reagent leading to a selective 
biotynilation of proteins that contain ROS-sensitive Cys residues. These 
experiments can easily be monitored by western blot analyses taking 
advantage of the high interaction of biotin with streptavidin that in turn can 
be used to selectively isolate and to identify the labelled proteins by 
immunotechniques. 
We first investigated weather BIAM was really able to react with free 
cysteine. Thus proteins were extracted in lysis buffer (RIPA) at pH 7, as 
described in material and methods. Cell lysate were incubated for 30 min at 
room temperature with 40 µM BIAM, a procedure that results in the rapid 
biotinylation of proteins containing low-pKa Cys residues. The BIAM-labeled 
reaction mixtures and the control (cell lysate not incubated with BIAM) were 
subjected affinity chromatography using streptavidin modified agarose 
beads as described in Material and Methods section. Eluted samples were 
separated by monodimensional SDS-PAGE and protein bands were blotted 
on a nitrocellulose membrane and detected with streptavidin HRP.   
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Blot analysis of the cell lysates revealed many proteins labeled with BIAM in 
exponential phase (Fig 20); many signals may be observed in the control 
too, but  these might be due to endogenous biotin containing proteins.  
Protein bands which gave positive signal to Western Blot analysis were 
submitted to an identification procedure by in situ hydrolysis, MALDI 
analysis of peptide mixtures and data bank interrogation, the results are 
summarized in table 1. 
 
Tab.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20  Mono dimensional SDS PAGE (A) and Western Blot analysis 
(B) of Cell lysate after BIAM labelling (lane 2 and 4) and not labelled 
with BIAM (lane 1 and 3)  
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Peptide spectra from in situ hydrolysis of the protein bands after proteins 
identifications, were manually analyzed in order to identify those signals 
which could be attributed to BIAM linked peptides.  
As an example, figure 21 shows partial peptide MALDI spectra of band 1 
corresponding to acetyl CoA carboxylase. The signal at m/z 1757.92 was 
attributed to 988-998 peptide carrying one BIAM group linked to Cys 993. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     Fig.21 
 
 
 However Tab. 1 shows, in some cases, the identification of more than one 
protein in a single band; therefore we decided to increase the resolutive 
power of the separation technique, therefore after BIAM labelling protein 
extracts were separated by bi-dimensional electrophoresis avoiding affinity 
purification step. 
Optimized protocol was therefore used to investigate whether at pH 7, the 
BIAM-labeled proteins amount change on different carbon source and 
during chronological aging. Yeast cells grown in SCD, CR and SCG were 
harvested in exponential phase and at different time during chronological 
aging (24h and 72h) see figure 22.  
 
 
 
 
HYQPLCKLSSK 
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Growth in SCD resulted in a time–depending decrease in the extent of BIAM 
labelling of these proteins. In fact after 24 hours, BIAM-linked proteins 
profile, of yeast growth in SCD, is drastically reduced. In contrast during 
growth in CR or in SCG is evident the BIAM-labeled protein level is only 
weakly modified during all the time of analysis indicating a prevalence of 
reduced form of cystein during aging. In order to better evaluate the 
cysteine oxidation process in chronological ageing in SCD, protein lysates 
were prepared from cells in the exponential phase and after 72 h growth 
and incubated with BIAM. Proteins were separated by 2D-gel 
electrophoresis and the BIAM-labelled proteins revealed by Western blot. 
The results shown in figure 23 indicates that many proteins are in a reduced 
form (BIAM-linked) during exponential phase (Figure 23A) whereas at 72h a 
dramatically decrease of the BIAM labeled proteins is evident indicating a 
prevalence of oxidized cysteine residues (Figure 23B). Since we previously 
 
Fig.22 Comassie staining and blot analysis with HRP-conjugate 
streptavidin of protein extract from yeast grown in SCD, CR and 
SCG. Yeast cells were harvest in exponential phase (lane 1), and 
after 24 and 72 hours of growth (lane 2 and 3 respectively) 
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observed that chronological aged cells on SCG or in CR present a reduction 
of ROS level and a reduction on oxidized  proteins as evaluated with BIAM 
labelling by 1D electrophoresis  (Fig.22) we performed the same experiment 
separing the lysates by 2D electrophoresis. Western blot with HRP-
conjugated streptavidin and ECL of 2D-gels from cells grown for 72 h in CR 
or SCG showed an increase in BIAM-labelling (Figure 23C and 23D 
respectively) in comparison to the same experiment from cells grown in 
SCD (Figure 23B).  
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Fig.23 
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4.5 Image analysis and Identification of major proteins oxidized on cysteine 
residues. 
Streptavidin immunostained gels of protein lysates from yeast cells grown in 
SCD both in the exponential phase and during ageing (72 h) were 
compared by using the MELANIE 4.0 software. We were also able to 
compare different gels, in order to localize spots corresponding to proteins 
with an alteration in cysteine redox state during cell chronological ageing in 
different growth conditions.   
During growth in exponential phase in SCD about 50 spots corresponding to 
BIAM-linked proteins were clearly  detected in repeated trials (Figure 23A). 
Among these, 9 spots correspond to proteins that are still reduced on 
cysteine residues after 72h in SCD (Figure 23A and 23B red circles). 
Moreover 10 spots corresponded to proteins that were not visible during 
ageing even when the gels were silver stained suggesting that these 
proteins might not be expressed at detectable level in the late stationary 
phase (data not shown).  
Finally, the image analysis identified 31 spots (indicated by black circles) 25 
(indicated by black circles and number in Figure 23A) and the redox status 
of these spots were analysed, by BIAM-labelling, in chronological aged cells 
growth in CR (Figure 23C) and in SCG (Figure 23D) respectively. 
The locations of the identified spots were marked with numbers in a 
representative gel shown in Figure 24 where proteins were visualized by 
silver staining.  
Proteins excised from the gel, were reduced, alkylated and in situ digested 
with trypsin and the resulting peptide mixtures were directly analysed by 
MALDI/MS according to the peptide mass fingerprinting procedure. Peaks 
detected in the MALDI spectra were used to search for a non redundant 
sequence database using the in house MASCOT software, taking 
advantage of the specificity of trypsin and the taxonomic category of the 
samples. The set of experimental mass values was compared to the 
theoretically predicted peptides from the proteins in the explored database.  
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The number of measured masses that matched within the given mass 
accuracy of 200 ppm was recorded and the proteins that received the 
highest number of peptide matches were examined. The probability score of 
the second best candidate identified by the program was several orders of 
magnitude lower. This approach was employed for the identification of all 
protein bands indicated and a summary of the results is reported in Table I. 
Sequences coverage of most relevant protein spot obtained mass spectral 
analyses are summarised in Table II. As indicated in the Tables II and III, 
several spots occurring at different molecular mass and isoelectric point 
were identified as corresponding to the same protein even if the peptides 
identified by MASCOT software clustered in different regions within amino 
acids sequence. This might be due to a proteolytic processing occurred 
during sample manipulation. It should be underlined that the spectra 
revealed the occurrence of some signals that could not be interpreted on the 
basis of the aminoacidic sequence by MASCOT software. These signals 
Fig. 24 2D-electrophoresis of total proteins from yeast cells grown in 2% 
glucose. Circles represent biotinylated protein in exponential phase (figure 
6 panel A) that undergo to oxidation during chronological aging in 2% 
glucose200  
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were then manually interpreted “a posteriori” as arising by the addition of 
one or more BIAM moieties to Cys-containing peptides. As an example 
Figure 24 shows the partial MALDI spectrum of  spot 1 corresponding to 
GAPDH. The signals at m/z 2159.11 and 2613.35 were attributed to 144-
160 peptide carrying one and two BIAM groups respectively, linked to Cys 
150 and 154. Additional data were obtained by nanoLC/MS/MS 
experiments. As indicated in Table II, several spots gave no confident 
identification by peptide mass fingerprinting. Thus the peptide mixtures were 
fractionated by nanoHPLC and sequence information were obtained by 
tandem mass spectrometry on an 4000QTrap linear ion trap instrument 
leading to the unambiguous identification of the protein candidate as 
reported in Table I. As evident from the Table I most of the enzymes from 
the glycolytic and fermentative pathways became oxidized in cysteine 
residues under cronological aging in media containing high glucose 
concentration, meanwhile cells grown  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.24  Partial MALDI spectrum of  spot 1 
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in CR or SCG, showed lower levels of protein oxidation on their cysteines. 
Several major spots from 1 to 4 correspond to glyceraldehyde 3-phosphate 
dehydrogenase 3 (GAPDH 3) an enzyme involved in glycolysis and 
gluconeogenesis. Six spots identified in western blot from cells grown on 
CR or SCG as BIAM-labelled, correspond to a major of three pyruvate 
decarboxylase isozymes (spots from 6 to 11). Enolase 1 (Spots 13 and 14) 
and Enolase 2 (spots 12, 15 and 16) are phosphopyruvate hydratases 
involved in the conversion of 2-phosphoglycerate to phosphoenolpyruvate 
during glycolysis and the reverse reaction during gluconeogenesis. Two 
proteins identified as unique spots belong to glycolysis or gluconeogenesis 
namely phosphoglycerate kinase (spot 22) and fructose-1,6-bisphosphate 
aldolase (spot 24). Spots 17 and 18 resulting in identification of actin, and 
spots 20 and 21 are MS identified as mannose-1-phosphate 
guanyltransferase, two proteins both required for normal cell wall structure. 
Actin is a structural protein involved in many cytoskeletal functions like cell 
wall organization and biogenesis and mannose-1-phosphate 
guanyltransferase is an enzyme responsible of cell wall biosynthesis.  
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Spot pI/MW(Da
) teor. 
pI/MW(KDa) 
2DE 
Mascot 
score 
N°of 
peptide
s 
Sequence 
coverage  
(%) 
Protein Accessi
on 
number 
1* 6.49/3570
7 
6.8/32.77 470 33 69 glyceraldehyde-3-
phosphate 
dehydrogenase 3 
P00359 
2* 6.49/3570
7 
6.5/21.01 321 23 46 glyceraldehyde-3-
phosphate 
dehydrogenase 3 
P00359 
3* 6.49/3570
7 
6.25/20.92 127 12 22 glyceraldehyde-3-
phosphate 
dehydrogenase 3 
P00359 
4# 6.49/3580
7 
6.72/19.73 423  
VLPELQGK 
VVDLVEHVAKAK 
AVGKVLPELQGK 
TASGNIIPSSTGAAK 
LNKETTYDEIKK 
GGRTASGNIIPSSTGAAK 
TASGNIIPSSTGAAKAVG
K 
IVSNASCTTNCLAPLAK 
 
glyceraldehyde-3-
phosphate 
dehydrogenase 2 
P00358 
5* 5.98/4856
8 
6.29/45.53 134 13 30 protein 
MET17includes: 
O-
acetylhomoserine 
sulfhydrylase 
P06106 
6* 5.8/61554 6.15/48.86 238 24 46 pyruvate 
decarboxylase 
isozyme 1 
P06169 
7* 5.8/61554 6.0/56.62 447 56 56 pyruvate 
decarboxylase 
isozyme 1 
P06169 
8# 5.8/61554 5.41/25.65 54  Q-trap pyruvate 
decarboxylase 
isozyme 1 
P06169 
9* 5.8/61554 6.09/25.02 73 17 7 pyruvate 
decarboxylase 
isozyme 1 
P06169 
10# 5.8/61554 5.09/27.47 291  
LLTTIADAAK 
NATFPGVQMK 
TPANAAVPASPLK 
NPVILADACCSR 
DAKNPVILADACCSR 
 
pyruvate 
decarboxylase 
isozyme 1 
P06169 
11 5.80/6155
4 
6.46/25.51 82 8 21 pyruvate 
decarboxylase 
isozyme 1 
P06169 
12* 5.67/4681
1 
6.06/31.49 205 17 32 Enolase 2 P00925 
13* 6.17/4669
9 
6.59/45.69 392 42 65 Enolase 1 P00924 
14# 5.67/4681
1 
5.5/32.04 467  
AAAAEKNVPL 
YQHLADLSK 
IGSEVYHNLK 
IGLDCASSEFFK 
NVPLYQHLADLSK 
AVDDFLLSLDGTANK 
Enolase 1 P00924 
15* 5.67/4681
1 
5.66/44.04 345 27 47 Enolase 2 P00925 
16# 5.67/4681
1 
5.82/22.87 350  
TFAEAMR 
IGSEVYHNLK 
IGLDCASSEFFK 
NVPLYQHLADLSK 
IGSEVYHNLKSLTK 
AVDDFLLSLDGTANKSK 
 
Enolase 2 P00925 
17* 5.44/4189
1 
5.24/42.28 138 11 27 Actin P60010 
18# 5.44/4189
1 
5.34/25.14 206  Q-trap Actin P60010 
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(*) see Table III 
 (#) identified by LC/MSMS analisys 
 
TABLE II 
Proteins identified 
19* 6.26/3703
4 
6.0/29.83 92 5 27 Alcohol 
dehydrogenase I 
P00331 
20* 5.95/3971
2 
6.01/26.77 111 12 29 Mannose-1-
phosphate 
guanyltransferase 
P41940 
21* 5.95/3971
2 
6.15/37.56 143 12 32 Mannose-1-
phosphate 
guanyltransferase 
P41940 
22* 7.10/4463
7 
6.88/43.07 423 38 75 Phosphoglycerate 
kinase 
P00560 
23* 
 
8.31/2373
4 
5.15/25.94 434 33 72 Heat shock protein 
26 
P15992 
24* 5.51/3975
0 
5.03/32.04 180 19 31 fructose-1,6-
bisphosphate 
aldolase 
P14540 
25# 
 
 
9.14/5040
0 
6.89/19.03 169 IGGIGTVPVGR 
FQEIVKETSNFIK 
VETGVIKPGMVVTFAPAG
VTTEVK 
Elongation factor 1-
alpha 
P02994 
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TABLE III 
           Sequence coverage of identified proteins 
 
 
 
 
 
1 
   
   1 VRVAINGFGR IGRLVMRIAL SRPNVEVVAL NDPFITNDYA AYMFKYDSTH  
    51 GRYAGEVSHD DKHIIVDGKK IATYQERDPA NLPWGSSNVD IAIDSTGVFK  
   101 ELDTAQKHID AGAKKVVITA PSSTAPMFVM GVNEEKYTSD LKIVSNASCT  
  151 TNCLAPLAKV INDAFGIEEG LMTTVHSLTA TQKTVDGPSH KDWRGGRTAS  
   201 GNIIPSSTGA AKAVGKVLPE LQGKLTGMAF RVPTVDVSVV DLTVKLNKET  
   251 TYDEIKKVVK AAAEGKLKGV LGYTEDAVVS SDFLGDSHSS IFDASAGIQL  
   301 SPKFVKLVSW YDNEYGYSTR VVDLVEHVAK A 
 
 
15
 
1 AVSKVYARSV YDSRGNPTVE VELTTEKGVF RSIVPSGAST GVHEALEMRD  
51 EDKSKWMGKG VMNAVNNVNN VIAAAFVKAN LDVKDQKAVD DFLLSLDGTA  
101 NKSKLGANAI LGVSMAAARA AAAEKNVPLY QHLADLSKSK TSPYVLPVPF  
  151 LNVLNGGSHA GGALALQEFM IAPTGAKTFA EAMRIGSEVY HNLKSLTKKR  
   201 YGASAGNVGD EGGVAPNIQT AEEALDLIVD AIKAAGHDGK VKIGLDCASS  
   251 EFFKDGKYDL DFKNPESDKS KWLTGVELAD MYHSLMKRYP IVSIEDPFAE  
   301 DDWEAWSHFF KTAGIQIVAD DLTVTNPARI ATAIEKKAAD ALLLKVNQIG  
   351 TLSESIKAAQ DSFAANWGVM VSHRSGETED TFIADLVVGL RTGQIKTGAP  
   401 ARSERLAKLN QLLRIEEELG DKAVYAGENF HHGDKL 
 
2  1 VRVAINGFGR IGRLVMRIAL SRPNVEVVAL NDPFITNDYA AYMFKYDSTH  
    51 GRYAGEVSHD DKHIIVDGKK IATYQERDPA NLPWGSSNVD IAIDSTGVFK  
   101 ELDTAQKHID AGAKKVVITA PSSTAPMFVM GVNEEKYTSD LKIVSNASCT  
  151 TNCLAPLAKV INDAFGIEEG LMTTVHSLTA TQKTVDGPSH KDWRGGRTAS  
   201 GNIIPSSTGA AKAVGKVLPE LQGKLTGMAF RVPTVDVSVV DLTVKLNKET  
   251 TYDEIKKVVK AAAEGKLKGV LGYTEDAVVS SDFLGDSHSS IFDASAGIQL  
   301 SPKFVKLVSW YDNEYGYSTR VVDLVEHVAK A 
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1 MDSEVAALVI DNGSGMCKAG FAGDDAPRAV FPSIVGRPRH QGIMVGMGQK  
    51 DSYVGDEAQS KRGILTLRYP IEHGIVTNWD DMEKIWHHTF YNELRVAPEE  
   101 HPVLLTEAPM NPKSNREKMT QIMFETFNVP AFYVSIQAVL SLYSSGRTTG  
   151 IVLDSGDGVT HVVPIYAGFS LPHAILRIDL AGRDLTDYLM KILSERGYSF  
   201 STTAEREIVR DIKEKLCYVA LDFEQEMQTA AQSSSIEKSY ELPDGQVITI  
   251 GNERFRAPEA LFHPSVLGLE SAGIDQTTYN SIMKCDVDVR KELYGNIVMS  
   301 GGTTMFPGIA ERMQKEITAL APSSMKVKII APPERKYSVW IGGSILASLT  
   351 TFQQMWISKQ EYDESGPSIV HHKCF 
 
3  1 VRVAINGFGR IGRLVMRIAL SRPNVEVVAL NDPFITNDYA AYMFKYDSTH  
    51 GRYAGEVSHD DKHIIVDGKK IATYQERDPA NLPWGSSNVD IAIDSTGVFK  
   101 ELDTAQKHID AGAKKVVITA PSSTAPMFVM GVNEEKYTSD LKIVSNASCT  
   151 TNCLAPLAKV INDAFGIEEG LMTTVHSLTA TQKTVDGPSH KDWRGGRTAS  
   201 GNIIPSSTGA AKAVGKVLPE LQGKLTGMAF RVPTVDVSVV DLTVKLNKET  
   251 TYDEIKKVVK AAAEGKLKGV LGYTEDAVVS SDFLGDSHSS IFDASAGIQL  
   301 SPKFVKLVSW YDNEYGYSTR VVDLVEHVAK A 
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1 SIPETQKAII FYESNGKLEH KDIPVPKPKP NELLINVKYS GVCHTDLHAW  
51 HGDWPLPTKL PLVGGHEGAG VVVGMGENVK GWKIGDYAGI KWLNGSCMAC  
   101 EYCELGNESN CPHADLSGYT HDGSFQEYAT ADAVQAAHIP QGTDLAEVAP  
   151 ILCAGITVYK ALKSANLRAG HWAAISGAAG GLGSLAVQYA KAMGYRVLGI  
   201 DGGPGKEELF TSLGGEVFID FTKEKDIVSA VVKATNGGAH GIINVSVSEA  
   251 AIEASTRYCR ANGTVVLVGL PAGAKCSSDV FNHVVKSISI VGSYVGNRAD  
   301 TREALDFFAR GLVKSPIKVV GLSSLPEIYE KMEKGQIAGR YVVDTSK 
 
5  1 PSHFDTVQLH AGQENPGDNA HRSRAVPIYA TTSYVFENSK HGSQLFGLEV  
51 PGYVYSRFQN PTSNVLEERI AALEGGAAAL AVSSGQAAQT LAIQGLAHTG  
101 DNIVSTSYLY GGTYNQFKIS FKRFGIEARF VEGDNPEEFE KVFDERTKAV  
151 YLETIGNPKY NVPDFEKIVA IAHKHGIPVV VDNTFGAGGY FCQPIKYGAD  
201 IVTHSATKWI GGHGTTIGGI IVDSGKFPWK DYPEKFPQFS QPAEGYHGTI  
251 YNEAYGNLAY IVHVRTELLR DLGPLMNPFA SFLLLQGVET LSLRAERHGE  
301 NALKLAKWLE QSPYVSWVSY PGLASHSHHE NAKKYLSNGF GGVLSFGVKD  
351 LPNADKETDP FKLSGAQVVD NLKLASNLAN VGDAKTLVIA PYFTTHKQLN  
401 DKEKLASGVT KDLIRVSVGI EFIDDIIADF QQSFETVFAG QKP 
 
 
20
 
1 MKGLILVGGY GTRLRPLTLT VPKPLVEFGN RPMILHQIEA LANAGVTDIV  
    51 LAVNYRPEVM VETLKKYEKE YGVNITFSVE TEPLGTAGPL KLAEDVLKKD  
   101 NSPFFVLNSD VICEYPFKEL ADFHKAHGGK GTIVATKVDE PSKYGVIVHD  
   151 IATPNLIDRF VEKPKEFVGN RINAGLYILN PEVIDLIEMK PTSIEKETFP  
  201 ILVEEKQLYS FDLEGFWMDV GQPKDFLSGT VLYLNSLAKR QPKKLATGAN  
   251 IVGNALIDPT AKISSTAKIG PDVVIGPNVT IGDGVRITRS VVLCNSTIKN  
   301 HSLVKSTIVG WNSTVGQWCR LEGVTVLGDD VEVKDEIYIN GGKVLPHKSI  
   351 SDNVPKEAII M 
 
 
6 
 
1 SEITLGKYLF ERLKQVNVNT VFGLPGDFNL SLLDKIYEVE GMRWAGNANE  
    51 LNAAYAADGY ARIKGMSCII TTFGVGELSA LNGIAGSYAE HVGVLHVVGV  
   101 PSISAQAKQL LLHHTLGNGD FTVFHRMSAN ISETTAMITD IATAPAEIDR  
   151 CIRTTYVTQR PVYLGLPANL VDLNVPAKLL QTPIDMSLKP NDAESEKEVI  
   201 DTILALVKDA KNPVILADAC CSRHDVKAET KKLIDLTQFP AFVTPMGKGS  
   251 IDEQHPRYGG VYVGTLSKPE VKEAVESADL ILSVGALLSD FNTGSFSYSY  
   301 KTKNIVEFHS DHMKIRNATF PGVQMKFVLQ KLLTTIADAA KGYKPVAVPA  
   351 RTPANAAVPA STPLKQEWMW NQLGNFLQEG DVVIAETGTS AFGINQTTFP  
   401 NNTYGISQVL WGSIGFTTGA TLGAAFAAEE IDPKKRVILF IGDGSLQLTV  
   451 QEISTMIRWG LKPYLFVLNN DGYTIEKLIH GPKAQYNEIQ GWDHLSLLPT  
   501 FGAKDYETHR VATTGEWDKL TQDKSFNDNS KIRMIEIMLP VFDAPQNLVE  
   551 QAKLTAATNA KQ 
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1 MKGLILVGGY GTRLRPLTLT VPKPLVEFGN RPMILHQIEA LANAGVTDIV  
    51 LAVNYRPEVM VETLKKYEKE YGVNITFSVE TEPLGTAGPL KLAEDVLKKD  
   101 NSPFFVLNSD VICEYPFKEL ADFHKAHGGK GTIVATKVDE PSKYGVIVHD  
   151 IATPNLIDRF VEKPKEFVGN RINAGLYILN PEVIDLIEMK PTSIEKETFP  
   201 ILVEEKQLYS FDLEGFWMDV GQPKDFLSGT VLYLNSLAKR QPKKLATGAN  
   251 IVGNALIDPT AKISSTAKIG PDVVIGPNVT IGDGVRITRS VVLCNSTIKN  
   301 HSLVKSTIVG WNSTVGQWCR LEGVTVLGDD VEVKDEIYIN GGKVLPHKSI  
   351 SDNVPKEAII M 
 
7 
 
  
 1 SEITLGKYLF ERLKQVNVNT VFGLPGDFNL SLLDKIYEVE GMRWAGNANE  
    51 LNAAYAADGY ARIKGMSCII TTFGVGELSA LNGIAGSYAE HVGVLHVVGV  
   101 PSISAQAKQL LLHHTLGNGD FTVFHRMSAN ISETTAMITD IATAPAEIDR  
   151 CIRTTYVTQR PVYLGLPANL VDLNVPAKLL QTPIDMSLKP NDAESEKEVI  
   201 DTILALVKDA KNPVILADAC CSRHDVKAET KKLIDLTQFP AFVTPMGKGS 
   251 IDEQHPRYGG VYVGTLSKPE VKEAVESADL ILSVGALLSD FNTGSFSYSY  
   301 KTKNIVEFHS DHMKIRNATF PGVQMKFVLQ KLLTTIADAA KGYKPVAVPA  
  351 RTPANAAVPA STPLKQEWMW NQLGNFLQEG DVVIAETGTS AFGINQTTFP  
   401 NNTYGISQVL WGSIGFTTGA TLGAAFAAEE IDPKKRVILF IGDGSLQLTV  
   451 QEISTMIRWG LKPYLFVLNN DGYTIEKLIH GPKAQYNEIQ GWDHLSLLPT  
   501 FGAKDYETHR VATTGEWDKL TQDKSFNDNS KIRMIEIMLP VFDAPQNLVE  
   551 QAKLTAATNA KQ 
 
 
22
 
   1 SLSSKLSVQD LDLKDKRVFI RVDFNVPLDG KKITSNQRIV AALPTIKYVL   
   51 EHHPRYVVLA SHLGRPNGER NEKYSLAPVA KELQSLLGKD VTFLNDCVGP  
  101 EVEAAVKASA PGSVILLENL RYHIEEEGSR KVDGQKVKAS KEDVQKFRHE  
  151 LSSLADVYIN DAFGTAHRAH SSMVGFDLPQ RAAGFLLEKE LKYFGKALEN  
   201 PTRPFLAILG GAKVADKIQL IDNLLDKVDS IIIGGGMAFT FKKVLENTEI  
   251 GDSIFDKAGA EIVPKLMEKA KAKGVEVVLP VDFIIADAFS ADANTKTVTD  
  301 KEGIPAGWQG LDNGPESRKL FAATVAKAKT IVWNGPPGVF EFEKFAAGTK  
   351 ALLDEVVKSS AAGNTVIIGG GDTATVAKKY GVTDKISHVS TGGGASLELL  
   401 EGKELPGVAF LSEKK 
 
 
12 
   
1 AVSKVYARSV YDSRGNPTVE VELTTEKGVF RSIVPSGAST GVHEALEMRD  
  51 EDKSKWMGKG VMNAVNNVNN VIAAAFVKAN LDVKDQKAVD DFLLSLDGTA  
  101 NKSKLGANAI LGVSMAAARA AAAEKNVPLY QHLADLSKSK TSPYVLPVPF  
   151 LNVLNGGSHA GGALALQEFM IAPTGAKTFA EAMRIGSEVY HNLKSLTKKR  
   201 YGASAGNVGD EGGVAPNIQT AEEALDLIVD AIKAAGHDGK VKIGLDCASS  
   251 EFFKDGKYDL DFKNPESDKS KWLTGVELAD MYHSLMKRYP IVSIEDPFAE  
   301 DDWEAWSHFF KTAGIQIVAD DLTVTNPARI ATAIEKKAAD ALLLKVNQIG  
   351 TLSESIKAAQ DSFAANWGVM VSHRSGETED TFIADLVVGL RTGQIKTGAP  
   401 ARSERLAKLN QLLRIEEELG DKAVYAGENF HHGDKL 
 
 
23
 
1 SFNSPFFDFF DNINNEVDAF NRLLGEGGLR GYAPRRQLAN TPAKDSTGKE  
   51 VARPNNYAGA LYDPRDETLD DWFDNDLSLF PSGFGFPRSV AVPVDILDHD  
   101 NNYELKVVVP GVKSKKDIDI EYHQNKNQIL VSGEIPSTLN EESKDKVKVK  
   151 ESSSGKFKRV ITLPDYPGVD ADNIKADYAN GVLTLTVPKL KPQKDGKNHV  
   201 KKIEVSSQES WGN 
 
13 
 
1 AVSKVYARSV YDSRGNPTVE VELTTEKGVF RSIVPSGAST GVHEALEMRD  
  51 GDKSKWMGKG VLHAVKNVND VIAPAFVKAN IDVKDQKAVD DFLISLDGTA  
 101 NKSKLGANAI LGVSLAASRA AAAEKNVPLY KHLADLSKSK TSPYVLPVPF  
   151 LNVLNGGSHA GGALALQEFM IAPTGAKTFA EALRIGSEVY HNLKSLTKKR  
   201 YGASAGNVGD EGGVAPNIQT AEEALDLIVD AIKAAGHDGK VKIGLDCASS  
  251 EFFKDGKYDL DFKNPNSDKS KWLTGPQLAD LYHSLMKRYP IVSIEDPFAE  
   301 DDWEAWSHFF KTAGIQIVAD DLTVTNPKRI ATAIEKKAAD ALLLKVNQIG  
  351 TLSESIKAAQ DSFAAGWGVM VSHRSGETED TFIADLVVGL RTGQIKTGAP  
   401 ARSERLAKLN QLLRIEEELG DNAVFAGENF HHGDKL 
 
 
24
   
 1 GVEQILKRKT GVIVGEDVHN LFTYAKEHKF AIPAINVTSS STAVAALEAA  
    51 RDSKSPIILQ TSNGGAAYFA GKGISNEGQN ASIKGAIAAA HYIRSIAPAY  
  101 GIPVVLHSDH CAKKLLPWFD GMLEADEAYF KEHGEPLFSS HMLDLSEETD  
  151 EENISTCVKY FKRMAAMDQW LEMEIGITGG EEDGVNNENA DKEDLYTKPE  
   201 QVYNVYKALH PISPNFSIAA AFGNCHGLYA GDIALRPEIL AEHQKYTREQ  
   251 VGCKEEKPLF LVFHGGSGST VQEFHTGIDN GVVKVNLDTD CQYAYLTGIR  
 301 DYVLNKKDYI MSPVGNPEGP EKPNKKFFDP RVWVREGEKT MGAKITKSLE  
   351 TFRTTNTL 
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5.Discussion 
 
 
In the complex field of biological processes, Proteomics offers the instruments 
to deeply understand the molecular mechanisms involved. However, the large 
amount of data produced needs to be interpreted and correlated in a very 
critical way. This research step requires a deeper study, and the analytical 
skills of the researcher must be accompanied by a sound biochemical 
background.  
In this study we have tried to find correlations between cellular ageing (using 
cells in different growth conditions, i.e. different carbon sources) and 
apoptosis. Our interest was addressed to the identifications of the proteins 
involved, in order to understand the biochemical mechanisms at the basis of 
this phenomenon.  
Apoptosis is a largely studied process with more than one thousand papers 
published only in the last year. This study constitutes a systematic approach 
to the investigation of ageing using the most modern analytical techniques.  
Yeast is a versatile and simple eukaryotic mode organism. 
 
Although yeasts have 
greater genetic 
complexity than 
bacteria, containing 3.5 
times more DNA than 
Escherichia coli cells, 
they share many of the 
technical advantages 
that permitted rapid 
progress in the 
molecular genetics of 
prokaryotes.  
Some of the properties that make yeast particularly suitable for biological 
studies include rapid growth, dispersed cells, the ease of replica plating and 
mutant isolation, a well-defined genetic system, and most important, a highly 
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versatile DNA transformation system. Unlike many other microorganisms, S. 
cerevisiae is viable with numerous markers. Being non pathogenic, yeast can 
be handled with little precautions. Large quantities of normal bakers’ yeast 
are commercially available and can provide a cheap source for biochemical 
studies.  
Nevertheless yeast biochemical processes show many features with those 
occurring in complex eukaryotes, including humans. 
The results reported showed that calorie restriction and respiration extend 
S.cerevisiae lifespan and that oxidative damage on cysteine residues in 
chronological-aged cells are different in cells grown on high glucose in 
comparison to cells grown in calorie restriction or in a respirable carbon 
source as glycerol. The viability of yeast strains varies dramatically in different 
media conditions. As reported by many authors, the growth in a reduced 
glucose media, extend life span relative to normal glucose. In our  conditions 
when respiration is the only way to produce ATP,  more than 40% of cells are 
viable after 10 days. Many authors have shown that an increase in the level of 
reactive oxygen species (ROS) lead to a shortening of life span. They 
propose that the increase of ROS production can depend on the nature of 
mitochondrial defects. It is well known that the increase of life span during 
chronological ageing depends on mitochondrial function. We demonstrated 
that the ROS production  during exponential phase, is almost the same in all 
the media analyzed. 
On the contrary we observed an increase in the ROS production in senescent 
cells grown on high glucose. We determined that the ROS production is less 
than 20% in senescent cells grown in CR or in a non-fermentable carbon 
source such as glycerol than in old cells grown on the high glucose medium. 
This reduction could be due to a more efficient electron transport in the 
mitochondrial respiratory chain or to a major protection of the cells against 
ROS or to a combination of both processes. In all the conditions and in old 
cells, the mitochondria display a typical morphology with extended tubular 
network located prevalently at the cell cortex showing a normal mitochondrial 
integrity. We suggest that a better mitochondrial metabolism occurring during 
respiration play a role in a life span-extending effect of CR and growth in a 
respiratory medium. We evaluated the mitochondrial function measuring the 
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oxygen consumption of the young and old yeast in SCD, CR and SCG. In the 
young cells and in all the conditions of growth,  the oxygen consumption rate 
had a similar value. We demonstrated a decreased routine respiration in 
senescent cells growth in high glucose in comparison to the cells growth on a 
non-fermentable carbon source. These observations suggest that yeast 
growth on a non-fermentable carbon source may contribute to a better 
activation of respiration increasing the rate of it. Plotting the respiratory rate 
against the amount of each kind of cytochrome, it is possible to see a linear 
relationship between these two parameters indicating that respiratory rate is 
mostly controlled by the amount of respiratory chain components. We showed 
that the cytochromes a a3, b, c1 and c are present in the yeast grown in all 
mediums  analyzed in young cells even if the cytochrome c was lower in the 
yeast grown in SCD in comparison to SCG and CR. This reduction was more 
pronounced in senescent cells. All these evidence suggested that the growth 
in high glucose leads to a reduced mitochondrial efficiency in chronological 
aging. In contrast in CR and in SCG (a respirable carbon source) the level of 
cytochrome c content doesn’t show any reduction from young to old cells and 
this is in agreement with a good efficiency of respiration due to an increase in 
capacity of the mitochondrial electron transport chain. 
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The results presented here revealed that these findings led to a decrease of 
ROS level and improved longevity during chronological ageing. We can 
conclude that, during respiration induced by calorie restriction or following a 
growth in a respirable carbon source, the well ageing is due to high metabolic 
activity of mitochondria but low ROS leakage from the respiratory chain. It is 
reported by many authors that restriction dietary intake increased the rate of 
oxygen consumption indicating an increase of mitochondrial respiration.  
When the mitochondrial activity is inhibited, the effects of calorie restriction in 
abolished, showing that a reduction on calorie intake seems to increase 
mitochondrial activity probably because of a more efficient extraction of 
energy from a limited amount of food. Recently Antebi A. (87) reported the 
identification of two genes that mediate the increase in longevity by calorie 
restriction in worms Caenorhabditis elegans.  
In this study we also suggest the possibility that increased and better 
mitochondrial activity might promote longevity triggering mechanisms that  
 
protect cells against oxidative stress or reduced the damage to cellular 
components like proteins. We described the oxidative damage caused by 
ROS generation on cysteine residues. We used a procedure based on the 
facts that: 1) Cys residues are selectively labelled with biotin-conjugated 
Carbohydrate 
metabolism  
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iodoacetamide (BIAM), 2) oxidized cysteines are not labelled with BIAM and 
3) the decrease in BIAM labelling, resulting from oxidation, can be monitored 
by western blot. The results obtained in this study indicated that many 
proteins were labelled with BIAM in exponential phase during growth in high  
glucose. In normal glucose the senescent cells showed a decrease in BIAM-
labelled proteins showing a prevalence of oxidized form of cysteine residues. 
On the contrary the chronological aged cells on a reduced glucose level or in 
glycerol, present a reduction of cys-oxidized residues. These experiments 
suggest that cells grown with CR or SCG showed a very low level of cysteine 
oxidation. This result is consistent with the rule of CR and growth in non-
fermentable carbon source extending chronological life span in yeast. It has 
been described that, in chronological aging, there was an increased protein 
carbonylation in comparison to young cells.  
 
These proteins targets include enzymes involved in glucose metabolism and 
actin, explaining why the replication rate decrease in the passage through the 
stationary phase. Most of the enzymes of the glycolytic pathway such as 
GAPDHp, which we found to contain at least one Cys residue BIAM-labelled, 
Pdc1p, Eno1p and Eno2p, Pgk1p and Fba1p, were identified as targets for 
oxidation in old cells growth in high level of glucose. 
On the contrary the old cells growth in calorie restriction or in glycerol, 
showed marked differences in protein labelling patterns in comparison to the 
same cells on normal glucose. The same proteins showed big differences in 
relative band intensity on the corresponding western-blots. It is interesting to 
observe that several spots corresponding to oxidized proteins on cysteine 
residues in SCD are not identified in western blots from cells grown in CR or 
SCG. Most of them are undetectable on the 2D-gel of the SCG cultures. One 
of these proteins corresponds to Pdc1. This enzyme is strongly expressed in 
fermenting yeast cells growing in a fermentative carbon source. This protein 
is expected to be low expressed upon a respiratory carbon source. Another of 
these protein correspond to alcohol dehydrogenase I the enzyme responsible 
for converting acetaldehyde to ethanol during fermentation. ADH1 is expected 
to be low expressed during growth in SCG a respiratory carbon source 
because it is specific for fermentation.  
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Actin (spot 17) has been found to be involved in many processes including 
transcription and cromatine structure. More recently has been demonstrated 
(88) that cysteines 285 and 374 of actin are important physiological sensors 
of intracellular oxidative stress and are regulators of programmed cell death 
during chronological aging. It is so evident that this protein is oxidized on 
cysteine residues after 72h in SCD. We evaluate the GSH level and  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interaction between DNA 
(blue) and actin (stained with 
fluorscein green) 
Donald E. Ingber, "The 
Architecture of Life" Scientific 
American, Jan. 1998 
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our preliminary results indicate that growth on CR and SCG promote an 
increase on this peptide affecting the antioxidant defense of yeast cells. This 
observation could be due to the need of glutathione in the thyol redox system, 
although this question requires further study. In summary, respiration induced 
by caloric restriction or by a respirable carbon source reduces cystein 
oxidative damage to proteins increasing life span in S.cerevisiae because in 
these conditions there is an increase in the capacity of the mitochondrial 
electron transport chain. Using the yeast S. cerevisiae as a model organism 
we showed a decrease in intracellular oxidation in old cells growth in low 
glucose or glycerol which results in better vitality of yeast cells.  
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Summary 
Apoptosis is a process of deliberate life relinquishment by a cell in a multicellular organism. It is 
one of the main types of programmed cell death (PCD), and involves an orchestrated series of 
biochemical events leading to a characteristic cell morphology and death. The apoptotic process is 
executed in such a way as to safely dispose of cell corpses and fragments. 
 
 
 
 
 
 
 
 
 
 
In contrast to necrosis, which is a form of traumatic cell death that results from acute cellular injury, 
apoptosis is carried out in an orderly process that generally confers advantages during an 
organism's life cycle. 
Apoptosis can occur when a cell is damaged beyond repair, infected with a virus, or undergoing 
stress conditions such as starvation or ageing. DNA damage from ionizing radiation or toxic 
chemicals can also induce apoptosis via the actions of the tumour-suppressing gene p53. The 
"decision" for apoptosis can come from the cell itself, from the surrounding tissue, or from a cell 
that is part of the immune system. In these cases apoptosis functions to remove the damaged cell, 
preventing it from sapping further nutrients from the organism, or to prevent the spread of viral 
infection. 
Yeast provides a simple and powerful model for the study of cellular complex mechanisms such as 
apoptosis caused by ageing, due to the presence of simplified regulatory pathways, comparing to 
more complex organisms, such as Homo sapiens.  
In yeast, two different forms of aging processes are studied: one is mother cell-specific aging  in 
which only the mother cell ages, while the daughter cell resets the clock to zero. 
 Age in this case is measured by cell generations, not by calendar time. The daughter cells remain 
in the stem cell pool while the other cell has made the first step towards differentiation. Resetting 
the clock is also known as ‘‘rejuvenation’’, a process which is absolutely necessary for survival of 
the yeast strain. 
The second process of aging that can be studied in yeast is chronological aging of postmitotic 
cells. This aging process simply is the process of deterioration and loss of viability of cells during 
stationary phase. Again, like in mother cell-specific replicative aging, chronological aging is a 
process of genetically controlled cell differentiation. To give an example, the cell wall of stationary 
cells undergoes genetically controlled structural changes and remodelling.  
A section of mouse liver showing an apoptotic cell indicated by 
an arrow 
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An increase in intracellular oxidative stress, in ROS and in “death factors” seems to be common to 
the two aging processes as reported by many authors. In both forms of ageing, the terminal yeast 
cells execute apoptosis. 
Reactive oxygen species generated by aerobic metabolism cause oxidative damage to cell 
macromolecules such as proteins, DNA and lipids inducing structure alteration and in many cases 
loss of function. It is now widely accepted that accumulation of these dysfunctional molecules 
during lifespan of the cell plays a key role in ageing process and degenerative diseases.  
Harman’s “free radical theory of aging” is now fifty years old; today although ROS are believed as 
the major cause of ageing many questions remains opened. In particular is not clear the 
relationship between metabolism rate and ROS production. Furthermore, although many 
molecules are found in oxidized state during cell senescence, is not clear which are the relevant 
targets of oxidation and how their modification can affect lifespan. 
The proteomic approach offers all the instruments to deeply understand the mechanisms of this 
phenomenon. The high capacity of the analytical technique used in proteomics to resolve complex 
mixture of proteins extracted from a cell and the very sensitive techniques used to identify them, 
led in the last few years to a better understanding of apoptosis. 
A procedure for detecting proteins that contain oxidation-sensitive cysteine residues, as a means 
to 
study protein oxidation from different growth conditions in yeast cells, was the main goal of this 
project. The procedure is based on the fact that biotin-conjugated iodoacetamide (BIAM) 
selectively reacts with free thiols in cysteine residues ( Fig 1), and that the decrease in the labelling 
of cell lysate proteins with BIAM can be monitored by western blot analysis.  
Thiol (SH) groups play a broad range of roles in the cell, since their redox state can affect the 
activity and the structure of enzymes, receptors and transcription factors.  
In this study we evaluated the redox state of proteins combining a selective method for labelling 
proteins containing reduced cysteine residues and mono/two dimensional electrophoresis followed 
BIAM 
Fig 1. Reaction between BIAM and cysteine thiol group
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by mass spectrometry. In fact cysteine residues can react with ROS and can function as detector 
of redox status of the cells. In particular we compared yeast cells exponentially growing with cells 
during chronological ageing.  
During the first year I have focused my attention to set up a method to label, to isolate and to 
identify those proteins from a S.cerevisiae extract which in consequence of oxidative stress, 
endured irreversible oxidations of cystein thiol groups. The BIAM-labeled reaction mixtures and the 
control (cell lysate not incubated with BIAM) were subjected to affinity chromatography using 
streptavidin modified agarose beads. Eluted samples were separated by monodimensional SDS-
PAGE, the separated proteins were transferred to a nitrocellulose membrane and detected with 
streptavidin HRP blot analysis (fig.2) 
Fig.2 Mono dimensional SDS PAGE (A) and Western Blot              
analysis (B) of Cell lysate after BIAM labelling (lane 2 and 4)  
and not labelled with BIAM (lane 1 and 3)                                              Tab. 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein bands which gave positive signal to Western Blot analysis were submitted to an 
identification procedure by in situ hydrolysis, MALDI analysis of peptide mixtures and data bank 
interrogation, the results are summarized in table 1. However tab. 1 shows, in some cases, the 
identification of more than one protein in a single band; therefore we decided to increase the 
resolutive power of the separation technique, therefore after BIAM labelling protein extracts were 
separated by bi-dimensional electrophoresis avoiding affinity purification step. We therefore 
decided during the second year to focus our attention to set up an optimized method for this 
separation.  
During this period we also set up a software image analysis of the two-dimensional maps and 
western blot, in order to identify the proteic spots corresponding to BIAM linked proteins and to 
identify spots which disappeared during ageing.   
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Example of image analysis 
 
Optimized protocol was therefore used to investigate whether at pH 7, the BIAM-labeled proteins 
amount change on different carbon source and during chronological aging. 
The experiments were performed in complete synthetic medium (SC) containing three different 
carbon source: glucose 2%, glucose 0,5% and 3% glycerol.  SC plus 2% glucose is the standard 
medium used from many authors to study the chronological aging features. In this condition yeast 
cells initially obtain energy through fermentation pathway and approximately after 10 hours, when 
the glucose concentration reaches very low level, yeasts switch to respiration pathway. This switch 
is called “diauxic shift” and then yeast enter in the post-diauxic phase. In this phase cells grow 
slowly until about 48 hours and then stop dividing but the metabolic rate remain high until 
approximately one week. SD plus 0,5% glucose is the medium used to mimic caloric restriction; in 
this condition yeast cells show an increase of life span probably through a decrease in ROS 
production although the mechanism involved in this reduction is still debated. For the fist time we 
also tested a role of a pour fermentable carbon source as glycerol on yeast chronological aging. In 
the last phase of the project, we first measured the vitality of the colonies grown on the different 
carbon sources. The results confirmed that both caloric restriction and non fermentable substrate 
prolonged vitality of yeasts. Furthermore we measured ROS production in yeast mithocondria 
(tanks to specific die) in the three colonies after 72 h. 2% glucose colonies showed a much bigger 
rate of ROS production, compared with the other two.  
In order to identify the major target of oxidation in chronological aging in SCD extracts of young 
(exponentially growing) and old (72h of growth) cells, lysates were incubated with 40 µM BIAM and 
the proteins submitted to 2D-GE followed by western blot anti-streptavidin. The results shown in 
figure 23 indicates that many proteins are in a reduced form (BIAM-linked) during exponential 
phase (Figure 2A) whereas at 72h a dramatically decrease of the BIAM labeled proteins is evident 
indicating a prevalence of oxidized cysteine residues (Figure 2B). 
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Western blot with HRP-conjugated streptavidin and ECL of 2D-gels from cells grown for 72 h in CR 
or SCG showed an increase in BIAM-labelling (Figure 2C and 2D respectively) in comparison to 
the same experiment from cells grown in SCD (Figure 2B). 
 
 
 
 
 
 
 
 
 
 
 
 
After an accurate image analysis using the MELANIE 4.0 software of the different repeated trials, 
we were able to localize on the 2D-GE spots corresponding to BIAM linked or non BIAM linked  
proteins. We were also able to compare different gels, in order to localize spots corresponding to 
proteins with an alteration in cysteine redox state during cell chronological ageing in different 
growth conditions.   
During growth in exponential phase in SCD about 50 spots corresponding to BIAM-linked proteins 
were clearly  detected in repeated trials (Figure 2A). Among these, 9 spots correspond to protein 
that are still reduced on cysteine residues after 72h in SCD (Figure 2A and 2B red circles) and 10 
spots correspond to proteins that are not visible in silver stained 2D-gel of old cells. These spots 
were excluded by our analysis because they are undetectable on the 2-D gel. Among the 
remaining 31 spots (indicated by black circles) 25 (indicated by black circles and number in Figure 
2A) were identified and the redox status of these spots were analysed, by BIAM-labelling, in 
chronological aged cells growth in CR (Figure 2C) and in SCG (Figure 2D) respectively. 
The results reported showed that calorie restriction and respiration extend S.cerevisiae lifespan 
and that oxidative damage on cysteine residues in chronological-aged cells are different in cells 
grown on high glucose in comparison to cells grown in calorie restriction or in a respirable carbon 
source as glycerol. The viability of yeast strains varies dramatically in different media conditions. 
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In this study we also suggest the possibility that increased and better mitochondrial activity might 
promote longevity triggering mechanisms that protect cells against oxidative stress or reduced the 
damage to cellular components like proteins. These proteins targets include enzymes involved in 
glucose metabolism and actin, explaining why the replication rate decrease in the passage through 
the stationary phase.  
 
 
 
 
 
 
 
 
 
 
 
Most of the enzymes of the glycolytic pathway such as GAPDHp, which we found to contain at 
least one Cys residue BIAM-labeled, Pdc1p, Eno1p and Eno2p, Pgk1p and Fba1p, were identified 
as targets for oxidation in old cells growth in high level of glucose. On the contrary the old cells 
growth in calorie restriction or in glycerol, showed marked differences in protein labelling patterns 
in comparison to the same cells on normal glucose. Respiration induced by caloric restriction or by 
a respirable carbon source reduces cystein oxidative damage to proteins increasing life span in 
S.cerevisiae because in these conditions there is an increase in the capacity of the mitochondrial 
electron transport chain. Using the yeast S. cerevisiae as a model organism we showed a 
decrease in intracellular oxidation in old cells growth in low glucose or glycerol which results in 
better vitality of yeast cells. 
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